Stockwinners Market Radar for March 24, 2020 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

20:17 EDT Pareteum discloses additional notice from Nasdaq - Pareteum announced that, as expected, the company received an additional delinquency notification letter from the Listing Qualifications Staff of The Nasdaq Stock Market due to the company's continued non-compliance with Nasdaq Listing Rule 5250(c)(1), as a result of the Company's failure to file its annual report on Form 10-K for the period ended December 31, 2019. The company intends to provide Nasdaq with an update to its compliance plan that addresses the delayed filing of the Form 10-K.

19:21 EDT Teck Resources: Fort Hills to be temporarily operated as single train facility - Teck Resources announced that in light of depressed prices for Western Canada Select, and to reduce negative cash flow from Fort Hills, the Partners in the Fort Hills limited partnership have decided to temporarily operate Fort Hills as a single train facility. Assuming ongoing production at Fort Hills on this basis through the balance of 2020, Suncor, as operator, advises that it now expects Fort Hills production to be approximately 100,000 to 120,000 barrels per day, of which Teck's share is 21.3%. Teck expects its 2020 share of Fort Hills production will be reduced to approximately 8 to 9 million barrels of bitumen, which will significantly reduce variable costs. However, unit costs for the remaining production will be higher as a result of fixed costs being covered by lower volumes. On the basis of these assumptions, unit operating costs are expected to be C$37 to C$40 per barrel. Work is ongoing to assess opportunities to reduce or defer capital spending on the project in the context of the new plan. The Fort Hills partners intend to monitor market conditions and may adjust the operating plan for Fort Hills accordingly.

19:03 EDT Nokia completes phase one of Zeebrugge digitalization with 5G-ready network - Nokia has announced that it has completed the first phase of Port of Zeebrugge's 5G-ready, industrial-grade private wireless network deployment. By deploying the Nokia Digital Automation Cloud platform, it will provide private wireless connectivity to more than 100 endpoints across the entire port operations. Following successful deployment of the Nokia private wireless network, Zeebrugge will be able to track, analyze and manage connected devices across multiple port-based applications in real time. The end-to-end, high-performance 5G-ready network will accelerate port innovation and automation with deployment of IoT, autonomous vehicles, augmented reality and drones.

18:56 EDT Align receives FDA 510k clearance for iTero Element 5D Imaging System in U.S. - Align Technology announced that the U.S. Food and Drug Administration has cleared the award winning iTero Element 5D Imaging System for commercial availability in the United States. The iTero Element 5D Imaging System expands the suite of existing high-precision, full-color imaging and fast scan times of the iTero Element intraoral scanner portfolio with a new clinical approach, optimized orthodontic and restorative dental workflows, and an improved doctor experience. In addition, iTero Element 5D Imaging System visualization tools improve patient engagement and communication by helping patients see and better understand their current dental health, their treatment plan options, and prescribed outcome on the iTero touchscreen, enabling better patient education, engagement, and compliance during treatment. Commenting on the announcement, Yuval Shaked, Align Technology senior vice president and managing director, iTero scanner and services business said, "The iTero Element 5D Imaging System seamlessly combines three key scanning technologies (3D data, intra-oral color photos and NIRI images) into one, integrated scan, and we are excited to bring this advancement in intraoral scanner technology to the U.S. market to help doctors provide better oral care for their patients. At the same time, we are mindful of the current environment and the impact that the COVID-19 pandemic is having across the world, and are focused solely on customer education regarding this new technology while so many dental practices in the U.S. are operating on a limited schedule."

18:47 EDT SPDR Gold Shares holdings rise to 935.98MT from 923.99MT - This is the second consecutive increase and the highest level of holdings since March 12th.

18:24 EDT Skyworks CEO: We've got a long way to go with 5G - In an interview on CNBC's Mad Money, Skyworks CEO Liam Griffin said we'll see a bigger roll-out of 5G in the second half of 2020. He noted that the roll-out of 5G has been delayed due to the coronavirus. "5G is a multi-year, thematic move and will bring major shifts to markets," Griffen added.

18:09 EDT Fortuna Silver Mines announces blockade to San Jose Mine - Fortuna Silver Mines reports that a group of individuals led by the former mayor of San Jose del Progreso, in the state of Oaxaca in Mexico, has illegally blockaded Federal Highway 175 and roads in the municipality of San Jose del Progreso, including access to the San Jose Mine, to protest the action taken by the Electoral Tribunal of the State of Oaxaca in revoking his appointment as mayor. As a result of the illegal blockade, the Company has temporarily halted mining and processing operations at the San Jose Mine. It maintains a taskforce on site to oversee critical activities to support the appropriate safety and environmental systems in place, and to ensure a prompt return to operations when the blockade is lifted.

18:02 EDT PRO-DEX says continuing business ops in CA under exemption - PRO-DEX announced its responses to COVID-19 and the current impacts of COVID-19 on its business. With headquarters and manufacturing facilities located in Irvine, California, the company is currently continuing business operations under an exemption from California Governor Newsom's Executive Order N-33-20 for "essential critical infrastructure sectors" based on our determination that we fall within the Healthcare and Public Health Sector exemption. "We currently remain open to both receive and ship orders, our manufacturing facility is continuing production, and, so far, we have not suffered any material impact due to COVID-19," PRO-DEX said. "However, due to uncertainties regarding the dynamics of COVID-19's spread and evolution, the effects on the economic activities of our customers and suppliers, and future measures that may be adopted in the markets in which we operate, it is impossible to predict the potential impact that the pandemic may have on our business." The company added that it has adjusted certain policies and procedures based on applicable national, state, and local emergency orders and safety guidance that may be issued from time to time, including: Non-essential employees that are able to work remotely are doing so; Increased frequency of disinfectant cleanings, especially for high-touch surfaces; Curtailed business travel; and multiple, staggered work shifts have been implemented in order to achieve effective social distancing. "While we have made changes to allow our business to continue to operate, we are committed to ensuring the safety of our employees, maintaining deliveries and services to our valued customers, and communicating closely with our suppliers." said Pro-Dex's CEO, Richard L. Van Kirk. "We are adapting quickly to new orders and guidance as they are released, but governmental restrictions on businesses continue to evolve. Due to uncertainties related to COVID-19, we do not know what adverse consequences may ultimately impact our operations or those of our critical suppliers or customers. Therefore, it is impossible at this time to predict the ultimate short-term or long-term impact of the pandemic on our business."

17:47 EDT Equifax says working on ways to minimize COVID-19 effects on consumer credit - Equifax said it is continuing to closely monitor the rapidly evolving COVID-19 situation and its significant financial impact on consumers and businesses around the globe. All businesses - particularly small and medium-sized businesses - are experiencing unprecedented disruption to supply and demand. As a result, the US and global economies face significant economic contraction and a rapid increase in unemployment. As a leader in credit reporting, Equifax and its affiliates support millions of consumers and thousands of businesses across 24 countries. Equifax said that, in the midst of the viral outbreak, it is actively working with creditors and lenders to minimize the effects this virus may have on consumers' credit standing. The company is working with policy makers around the globe, including the US Congress and the Consumer Financial Protection Bureau (CFPB), to implement actions that support consumers and businesses during this challenging crisis. In the US, Equifax is working with the Consumer Data Industry Association (CDIA) to mitigate the negative impact of the pandemic on consumers' credit files. The CDIA is providing important information to creditors and lenders regarding how they should report information during a natural disaster or for accounts placed in forbearance as a result of a natural or declared disaster. Consumers and businesses who are, or may be, impacted by COVID-19 are encouraged to contact their lenders and creditors directly to discuss their options. Equifax is engaged with many lenders, telecom and utility providers who are offering a variety of options to help people through forbearance and modified payment plans.

17:43 EDT Lockheed Martin awarded $932.84M Missile Defense Agency contract modification - Lockheed Martin was awarded a $932.84M modification to previously-awarded contract to exercise an option for the production of Terminal High Altitude Area Defense, or THAAD, interceptors and associated one-shot devices to support the U.S. government and the Kingdom of Saudi Arabia Foreign Military Sales, or KSA FMS, case requirements. The THAAD interceptors and associated one-shot devices will be procured under fixed-price incentive contract line items. The value of this contract is increased from $5.37B to $6,3B. The work has an expected completion date of April 1, 2026. FY20 procurement funds in the amount of $327.5M and KSA FMS funds in the amount of $605.34M are being obligated at time of award. The Missile Defense Agency is the contracting activity.

17:38 EDT Helios Technologies withdraws 2020 guidance due to COVID-19 - Helios Technologies provided a business update surrounding the COVID-19 pandemic and resulting uncertainty. Broad measures taken by governments, businesses and others to limit the spread of the virus are adversely affecting the company and its customers. Helios's global locations and production facilities remain fully operational at this time with the exception of the company's Faster facility in Italy. Government mandates in that country will require the temporary closure of the company's manufacturing location, which was and will remain open through March 25th for warehousing and shipping only. Effective March 26th, it will temporarily close until April 3rd, pursuant to the current mandate. Italian-based employees whose positions are amenable to remote work will continue to work from their homes and will continue to provide support to our customers. Helios is pleased to report that risk mitigation efforts undertaken in China have resulted in the successful reopening of its operations there. As a result of the evolving economic impact of COVID-19, the company believes that its 2020 financial results will be impacted, especially beginning in the second quarter, but the magnitude and duration of the impact is uncertain. In addition, production at any of its facilities may be further impacted as a result of possible future government, market or company actions due to COVID-19. For these reasons, Helios is withdrawing its 2020 guidance. The company plans to provide an update when it announces its first quarter results, currently scheduled for May 4, 2020.

17:31 EDT Village Farms says production facilities in Texas, Vancouver remain open - Village Farms said it has been closely monitoring the path of the Coronavirus Disease 2019 outbreak since it developed into a situation with global ramifications, and continues to monitor developments closely in real time. At this time, Village Farms' production facilities in Texas, Vancouver, Canada as well as its partner facilities in Ontario, Canada and Mexico, and Pure Sunfarms' facilities in Canada remain open. Village Farms and Pure Sunfarms already adhere to the highest health and safety standards in their operations and each has put in place heightened hygiene practices and safety protocols, including more stringent cleaning and sanitization, and are taking appropriate precautions throughout all operations as per the recommendations of health authorities. The company will continue to enhance and evolve such practices and protocols as the situation warrants, it said. "As we all know, these are unprecedented times, and our thoughts and prayers are with all those affected," said Michael DeGiglio, CEO Village Farms. "As it should be, our top priority at all times, and especially now, is to protect the safety and health of anybody that comes in contact with our products from planting through to the growing process and through to the ultimate consumption. We also have a commitment to our consumers to provide high quality produce as long as we meet our top priority, which, at this time, we continue to do. Some may question our decision to continue operations. As the founder and CEO of Village Farms, which has been a world-class fresh vegetable producer for more than 30 years, I am extremely proud of our unblemished food safety record. We have always not only met, but exceeded, our regulatory requirements. My personal goal has always been, and continues to be, that Village Farms lead the world in this regard. Our majority-owned cannabis producer, Pure Sunfarms' new facility was built with that as a critical underlying criterium. The technology being used is the best available today. Our customers, our consumers and our investors can be assured that, as good as we believe we are, our protocols are monitored and updated constantly so we have the ability to deal with any potential issue instantly. And I want to be clear that we will curtail or cease operations immediately at any of our individual operations should it become warranted. Our diversified footprint spanning three countries mitigates the potential impact of any such actions."

17:15 EDT PerkinElmer's coronavirus test receives EUA from FDA - PerkinElmer announced that the FDA has provided Emergency Use Authorization, or EUA, for the Company's New Coronavirus RT-PCR test. Clinical laboratories certified under Clinical Laboratory Improvement Amendments, or CLIA, can immediately begin using this kit to detect SARS-CoV-2, the virus that causes COVID-19. PerkinElmer's RT-PCR test is marketed as an in vitro diagnostic, or IVD, device by meeting the requirements of the European In Vitro Diagnostic Directive,, or IVDD, and is available in over 30 countries worldwide.

17:12 EDT Nike says it has reopened 80% of stores in China - Says living in unprecedented time. Says as of 45 days ago closed more than 5,000 stores in China. Says retail environment in China plummeted. Says leveraged digital app ecosystem. Says Nike training club in China saw extraordinary engagement and was up 80% by the end of Q3 compared to the beginning of the year. Says started opening up stores in China, with 80% back online. Says digital business in China has grown even further over the last month. Comments taken from Q3 earnings conference call.

17:02 EDT TSR names Thomas Salerno as new CEO - TSR announced that its board has appointed Thomas Salerno as President, CEO and Treasurer of the company effective March 23rd. Mr. Salerno has served as the Managing Director of TSR Consulting Services, the company's IT consulting services subsidiary and largest business unit.

17:01 EDT Hexo says remaining operational amid COVID-19 pandemic - Hexo Corp said it is confirming it is remaining operational on the heels of the cannabis sector being included as an essential workplace in Ontario and Quebec. "Given our role in supplying medical cannabis to patients and in the adult-use cannabis supply chain, our operations in Ontario and Quebec are to be maintained and our business is considered an essential workplace," said Sebastien St-Louis, CEO and co-founder of Hexo. "We are working to continue to ensure a steady supply of medical cannabis and consumer packaged goods. I am extremely grateful for our dedicated employees." Hexo said it is also carefully monitoring and assessing the evolving situation related to COVID-19 and the potential impact to its business, employees and customers. The company said it is working diligently to protect the health and safety of its employees and to ensure that there is no disruption to its supply of medical and adult-use cannabis. Production and manufacturing facilities remain open, with additional measures in place to allow the company to maintain the capacity needed to fulfil orders. Additional measures include: temporary restriction of visitors to facilities; work from home policy and support for employees who can do so; employees who feel unwell or have travelled are asked to stay home; hosting all meetings via digital tools; redeployment of employees for other parts of the business to support critical processes; significant investment into additional sanitation measures; consistent communication to employees with reminders and instructions on practicing good personal hygiene, including proper handwashing; and operational measures to support social distancing, such as staggered break schedules and workstations.

16:51 EDT Copart director sells 70.4K shares of common stock - In a regulatory filing, Copart disclosed that its director Daniel Englander sold 70.4K shares of common stock on March 20th. The total transaction size was $4.23M.

16:41 EDT Facebook seeing weakening in ads business due to COVID-19 pandemic - Facebook said in a blog post that it has seen a weakening in its ads business in countries taking aggressive actions to reduce the spread of COVID-19. "We have received questions about revenue, so want to provide some context here too: Much of the increased traffic is happening on our messaging services, but we've also seen more people using our feed and stories products to get updates from their family and friends," the company said. "At the same time, our business is being adversely affected like so many others around the world. We don't monetize many of the services where we're seeing increased engagement, and we've seen a weakening in our ads business in countries taking aggressive actions to reduce the spread of COVID-19. During this emergency, we're doing everything we can to keep our apps fast, stable and reliable. Our services were built to withstand spikes during events such as the Olympics or on New Year's Eve. However, those happen infrequently, and we have plenty of time to prepare for them. The usage growth from COVID-19 is unprecedented across the industry, and we are experiencing new records in usage almost every day. Maintaining stability throughout these spikes in usage is more challenging than usual now that most of our employees are working from home. We are working to keep our apps running smoothly while also prioritizing features such as our COVID-19 Information Center on Facebook as well as the World Health Organization's Health Alert on WhatsApp. We're monitoring usage patterns carefully, making our systems more efficient, and adding capacity as required. To help alleviate potential network congestion, we are temporarily reducing bit rates for videos on Facebook and Instagram in certain regions. Lastly, we're conducting testing and further preparing so we can quickly respond to any problems that might arise with our services." Reference Link

16:36 EDT Gladstone issues corporate update in shareholder letter - Gladstone announced that its executive leadership has issued the following letter to shareholders: "We wanted to provide you with a corporate update surrounding the COVID-19 pandemic, which has weighed on global financial markets and heavily impacted businesses. Our investment process has yielded a high-quality, diversified portfolio of properties. As of today, Gladstone Commercial's investment portfolio consists of 122 properties leased to 108 different tenants in 19 different industries. Our investment teams have invested over $1 billion of capital utilizing a credit-based approach that has resulted in a current occupancy of 98%. Since our IPO in 2003, our occupancy has never been below 96%. Over 84% of our annual rental revenue is derived from tenants that each represent on average less than 1% of our revenue. The remaining 16% of our annual rental revenue is derived from investment grade or investment grade equivalent tenants, or subsidiaries of investment grade companies. Our tenants in the Hospitality, Airlines and Oil & Gas industries comprise approximately 2.6% of our annual rental revenue. Gladstone Commercial has had only one tenant default in our history, an average annual default rate of less than 0.02% inclusive of the Great Financial Crisis of 2008-2010... As of today, we have received calls from two tenants representing approximately 2% of annual rental revenue stating that the COVID-19 pandemic may have a potential impact on their ability to meet their contractual obligations to us. We will continue to update our investors as events warrant. Our balance sheet has been structured conservatively. Gladstone has de-levered its balance sheet while maintaining substantial liquidity. From 2012 through 2019 we reduced our book leverage from 63% to 46% and currently have approximately $25 million of liquidity undrawn on our credit facility. Gladstone concluded 2019 with approximately $30 million in cash and an unused capacity on our committed line of credit. Our capital structure has minimal near-term debt exposure. In 2019 we proactively amended, extended and upsized our credit facility by increasing our term loan from $75 million to $160 million, inclusive of a delayed draw component, and increased our revolver from $85 million to $100 million, while extending the maturity date of our term loan for five years and extending the maturity date of our revolver for four years. We also added tier one banks such as Goldman Sachs and Wells Fargo to the Company's credit facility. This execution provided incremental likelihood of our ability to fund our business through recessionary uncertainty without significant disruption. Further, we extended the maturity date on $13 million of variable rate mortgage debt for a weighted average 2.4 years. Near term loan maturities are minimal with only $20 million and $27 million maturing in 2020 and 2021, respectively. Our recent Equity Capital Markets initiatives have reduced our recessionary liquidity risk... We also executed a refresh of our GOOD Common Stock and Series E Perpetual Preferred Stock's At-The-Market ("ATM") program with Goldman Sachs, Stifel and Baird as new active co-agents. In advance of the economic downturn, we raised $52 million in net proceeds via the GOOD Common Stock ATM program commencing in Q4 2019 through Q1 2020 to fund the equity component of acquisitions in tandem with previously raised equity and to maintain liquidity. We are positioned for growth, even contemplating current conditions. Our acquisition guidance for 2020 has been $125-$150 million, net of expected asset sales. While we anticipate limiting our investment activity in the short term, Q1 2020 acquisition volume was robust through March 9, 2020 having acquired $70 million of new investments at a 7.3% GAAP cap rate. The past four months acquisition volume through mid-March 2020 is $133 million at a 7.3% GAAP cap rate inclusive of $63 million of new investments from November 14th through December 31st, 2019 at a 7.4% GAAP cap rate. All our acquisitions in 2019-2020 are industrial properties. Acquisitions were concentrated at year end, having limited contribution to 2019 performance, but representing an excellent start to 2020. We at Gladstone have been closely monitoring the evolving situation of COVID-19 and are actively responding to the current conditions. Our Team is focused on staying connected to our clients and business partners as we collectively address the challenges before us with an expectation of succeeding together.

16:33 EDT T2 Biosystems announces global licensing pact of COVID-19 assay - T2 Biosystems announced that it has entered into a worldwide licensing agreement for a rapid COVID-19, novel coronavirus test developed by the Center of Discovery and Innovation at Hackensack Meridian Health, New Jersey's largest and most comprehensive health network. The licensed coronavirus assay has been used by healthcare professionals within the Hackensack Meridian Health network, under the U.S. Food and Drug Administration's Emergency Use Authorization guidance, to test and treat patients suspected of having coronavirus. Under terms of the agreement, T2 Biosystems will adapt the coronavirus test to run on its T2Dx Instrument, the same instrument used for the FDA-cleared T2Bacteria and T2Candida Panels. Hackensack Meridian Health will also adopt the T2Dx Instrument and test panels within its Center of Discovery and Innovation. "This agreement combines our FDA-cleared T2Dx platform with our joint scientific expertise to benefit patients at risk for both primary coronavirus infections, as well as associated secondary infections that may lead to sepsis," said John Sperzel, President and Chief Executive Officer of T2 Biosystems. "Data from prior flu pandemics indicated bacterial co-infection rates as high as 29%, and sepsis rates above 30% among patients admitted to hospital intensive care units. The ability to detect coronavirus and associated secondary bacterial or fungal infections that may lead to sepsis, without the need to wait days for a diagnostic result, allows clinicians to achieve targeted therapy faster, and can lead to reduced length of stay in the intensive care unit, freeing up beds for incoming patients."

16:32 EDT Norfolk Southern names Vanessa Allen Sutherland EVP, chief legal officer - Norfolk Southern Corporation announced that Vanessa Allen Sutherland has been named executive vice president and chief legal officer, effective April 1, 2020. "Vanessa is an invaluable contributor to NS, with important responsibilities across a number of areas critical to our company's success," said James A. Squires, Norfolk Southern chairman, president and CEO. "Most recently, Vanessa has been playing an integral role in helping NS navigate the economic, political, and regulatory environment. We thank her for her hard work and commitment to ensuring that our company continues to deliver superior returns for investors, and outstanding service to customers, while keeping our employees and communities safe. On behalf of the entire NS team, I congratulate Vanessa on her promotion to EVP." Allen Sutherland joined Norfolk Southern in 2018 as vice president law.

16:30 EDT 3M CEO says will not increase current pricing for respirators - 3M Chairman and Chief Executive Officer Mike Roman delivered the following letter to William Barr, attorney general of the United States; Larry Hogan, governor of Maryland and chair of the National Governors Association; and Tim Fox, attorney general of Montana and president of the National Association of Attorneys General, highlighting 3M's actions to curb counterfeiting and price gouging of personal protective equipment during the COVID-19 pandemic. The letter also urges federal and state governments and law enforcement officials to continue to lead the fight, with 3M's support and assistance, against those who are exploiting the crisis by marketing counterfeit products or gouging the public. "On behalf of 3M and our 96,000 employees worldwide, I would like to offer our support as you protect the public from counterfeiting and price-gouging with respect to critical medical devices, including the respirators and masks that are critical to our country's medical personnel," the CEO said. "This pandemic is affecting us all. 3M is doing all that it can to support public health and those impacted by this global health crisis. We are mobilizing all available resources and rapidly increasing output of critical supplies healthcare workers in the United States and around the world need to help protect their lives as they treat others. Since the COVID-19 outbreak, 3M has doubled its output of N95 respirators. We are running our manufacturing lines around the clock seven days a week, hiring workers, adding shifts, and activating more production lines. In addition, 3M is increasing its investment to expand its global capacity for manufacturing these respirators by more than 30 percent in the next 12 months. Here in the U.S., 3M currently manufactures more than 400 million N95 respirators annually. This production capacity, as well as our increased production of hand sanitizers and disinfectants, is critical to supporting healthcare workers and first responders. We are also in the process of working with logistics providers and large e-marketplace operators on a coordinated strategy and action plan to ensure products rapidly get to where they are needed most. 3M has not increased the prices it charges for respirators as a result of this global crisis. 3M will not increase its current pricing for respirators being used to help address the pandemic." "We are also in the process of working with large e-marketplace operators on a coordinated strategy and action plan to identify and remove counterfeiters and price-gougers and to refer them to the appropriate law enforcement authorities," Roman added. "In addition, we would welcome the opportunity to provide assistance to you as you seek to identify and hold individuals and organizations accountable for making counterfeit respirators or inflating prices."

16:21 EDT Broadmark Realty Capital launches Broadmark Private REIT, LLC - Broadmark Realty Capital announced the launch of Broadmark Private REIT, LLC. The goal of Broadmark Private REIT is to offer qualified purchasers the ability to participate in high-yield loans originated by Broadmark Realty Capital, Inc., through a private, non-traded fund structure, which will seek to replicate the structure of the previous Broadmark Real Estate Lending Companies. The Private REIT will raise capital each month in accordance with loan demand. "We are pleased to announce the launch of Broadmark Private REIT. In light of current market conditions, we believe that our differentiated strategy that focuses on short-term real-estate-backed senior mortgage loans will allow us to create meaningful value as we strategically deploy the capital on our fully unlevered balance sheet. Our current pipeline is strong and we remain committed to our vigilant underwriting standards, including ensuring that our borrowers have meaningful equity in their properties and requiring personal guarantees. We believe this is a unique offering which will provide an additional source of income for Broadmark," stated Jeff Pyatt, President and Chief Executive Officer.

16:20 EDT Hoegh LNG Partners provided an update on the challenges posed by COVID-19 - In light of the ongoing Covid-19 virus situation, Hoegh LNG Partners LP's sponsor, Hoegh LNG Holdings provided an update on how the Hoegh LNG Group is dealing with the associated challenges: operations and customers. The Hoegh LNG Group has implemented a number of mitigating measures to secure the health and safety of its employees and ensuring safe and continued operations for its customers. The list of measures includes, but is not limited to: the establishment of a Covid-19 task force monitoring the situation and performing relevant risk assessment on a continuous basis; the implementation of a work from home policy for all onshore employees on a worldwide basis; a "Lock down" on all vessels with no crew rotation and no visitors allowed onboard until further notice; the activation of the Hoegh LNG Group's crisis management plan. As of today, there are no known cases of coronavirus infection for any employees in the Hoegh LNG Group's offices or on any of its assets.

16:20 EDT EPR Properties announces $150M stock buyback - EPR Properties provided the following update regarding the evolving impact of COVID-19. The company announced that its board approved a limited share repurchase program in response to the extraordinary dislocation in the company's stock price. The company may repurchase up to $150 million of common share. CEO Greg Silvers says: "We have the ability to withstand the situation as we currently view it, given the company's strong balance sheet and liquidity position, including a precautionary draw on our line of credit. Also, in response to the market dislocation of our stock price, our board has authorized a limited share repurchase program which we will selectively deploy while carefully considering our liquidity position."

16:18 EDT PRA Health expands Mobile Health Platform in response to COVID-19 pandemic - As a response to the ongoing global COVID-19 pandemic, PRA Health Sciences announced the expansion of its Mobile Health Platform for remote clinical monitoring, adding several new capabilities that address sponsor needs for COVID-19 virtual study support. PRA's Mobile Health Platform, or MHP, engages with patients wherever they are. The app-based platform allows sponsors to do everything that's possible in a physician's office or clinical site, virtually. The new capabilities added to address COVID-19 are designed to support clinical trial sponsors and sites participating in clinical studies by allowing them to connect and coordinate with patients who are no longer able to travel to sites due to the current pandemic. Additionally, the mobile app can also be deployed to transition existing traditional, paper-based studies into more decentralized, siteless studies so that medical care and the evaluation of patients can continue during critical study timeframes.The mobile app features an administrative web app for investigators and sites, and a downloadable mobile app for patients, enabling sites to eConsent/re-consent patients for use of the mobile application, collect consent forms from patients to allow for delivery of investigational product through a third party courier, remotely schedule and conduct video consults with patients andeverage mobile survey tools to provide real-time insights to study investigators for potential action "As the COVID-19 pandemic continues, it will be increasingly difficult for patients to see their medical professionals in person or adhere to clinical study protocols requiring visits to sites and hospitals. Equally challenging and difficult is the ability for sites to keep up with both trial patients as well as COVID-19 patients," said Kent Thoelke, executive VP and CSO at PRA Health Sciences. "This mobile and remote solution allows critical studies to continue, where protocols and regulatory guidelines permit, and ensures that patient safety and wellbeing can be maintained during a time when social distancing and relieving the burden on our healthcare system is important in fighting COVID-19."

16:18 EDT Whitestone REIT 'taking prudent pause in making acquisitions' - Whitestone REIT provided a business update related to the impact of COVID-19."The health and safety of our employees, tenants and communities are Whitestone's top priority," said Jim Mastandrea, Chairman and Chief Executive Officer. "Given the important role of our shopping centers in the communities we serve, we are carefully monitoring the spread and impact of COVID-19 and taking proactive measures to maintain the strength of our business and ensure the continuity of operations, as local conditions permit. During this extraordinary period of uncertainty, we are taking a prudent pause in making acquisitions, and carefully evaluating development and redevelopment activities on a case-by-case basis. We are maintaining an open line of communication with our tenants, working closely and helping them apply for potential government subsidies when available.""We believe that our business model is resilient, as many stores at our properties currently remain open to provide essential goods and services to communities, such as grocery stores, convenience stores and pharmacies," Mr. Mastandrea added. "Additionally, many restaurants at our community-centered properties remain open and are providing take-out and/or delivery service to local neighborhoods. We are proud to continue serving the communities that rely on us for daily essentials, located in some of the largest markets in Texas and Arizona. All of us at Whitestone greatly appreciate the hard work of our employees, our tenants and the heroes on the front lines of this crisis - including our local police, fire and EMS professionals, and nurses, doctors and other health care providers."

16:16 EDT TransAct Technologies announces cost saving measures - TransAct Technologies announced a series of actions to enhance the company's financial flexibility in response to the unprecedented uncertainty related to the impact the novel coronavirus pandemic is having on the food service and casino industries. The cost reduction initiatives we are taking include the following: 10% across the board salary reduction for all salaried, non-commissioned employees; Reduction in sales commissions for all commissioned employees; 10% reduction of cash retainer fees for all non-employee directors; Furloughing approximately 10% of our workforce.

16:16 EDT Nike provides update on COVID-19 - "As discussed in our press release issued on February 4, 2020, operations in Greater China were materially impacted as a result of COVID-19," Nike said. "In the third quarter, on a currency-neutral basis, Greater China revenues were down 4 percent following 22 consecutive quarters of double-digit growth. However, during the first two months of the third quarter, Greater China's revenue grew strong double digits, offset by the impacts of COVID-19 beginning in late January. At the peak in February, roughly 75 percent of NIKE-owned and partner doors in Greater China were closed with others operating on reduced hours. Currently, nearly 80 percent of doors are open in Greater China with an even higher rate in key cities. Beginning March 16th, all NIKE-owned stores, outside of Greater China, Japan and Korea were closed to help curb the spread of COVID-19."

16:14 EDT Onconova announces completion of patient enrollment in INSPIRE trial - "Following significant progress throughout 2019, our team's immediate focus remains to advance our pivotal Phase 3 INSPIRE trial to the next milestone," said Steven Fruchtman, president and CEO. "We are excited to announce the completion of the planned enrollment of 360 patients in the INSPIRE trial in higher-risk (HR) MDS patients. INSPIRE represents one of the largest studies ever conducted in this patient population. Based on survival trends on the INSPIRE trial to date, we anticipate reporting topline survival data in the second half of 2020 and presenting the results at a medical meeting later this year. We continue to analyze deep genomic sequencing, including mutations of the Ras pathway, on these patients. Important genomic results were presented at ASH 2019 and additional data is expected to be presented at future medical meetings." Fruchtman continued, "We are also pleased about the progress of our plans for additional investigator-initiated studies - including the Phase 1/2a study of rigosertib plus nivolumab for the treatment of Stage IV KRAS mutated lung adenocarcinoma. We anticipate the first patient to be entered onto the trial once the COVID-19 environment improves sufficiently."

16:13 EDT Church & Dwight draws down $825M of its $1B credit facility - Church & Dwight announced measures it has taken to promote the safety of its employees, maintain its product supply to consumers and ensure the continuity of the business in response to the COVID-19 pandemic. These precautions include working from home where practical, temperature checking employees upon arriving at work locations, social distancing, restricting access to sites, flexible sick pay practices, frequent sanitization of work areas, and restrictions on business travel. All the company's manufacturing facilities and distribution centers currently remain open and continue to operate. Various state and local governments in the U.S. and other jurisdictions have required cessation of non-essential activities. Substantially all of the company's products are considered essential under applicable governmental requirements and guidance, including the Department of Homeland Security's March 19, 2020 Guidance on the Essential Critical Infrastructure Workforce. The company has taken steps to increase short term manufacturing capacity for its cleaning products and health care products and is working closely with its suppliers and retail partners to ensure sustained supply to keep pace with increased demand. Future restrictions on business operations or other developments related to the COVID-19 pandemic could potentially result in significant disruption to our business. As a result, out of an abundance of caution, thecompany has drawn $825mm of its $1B revolving credit facility and will hold the cash on its balance sheet for the foreseeable future. Cash on hand at March 31, 2020 is expected to be approximately $1 billion.

16:11 EDT Diffusion Pharmaceuticals to delay enrollment in PHAST-TSC trial due to COVID-19 - Diffusion Pharmaceuticals announced that it expect delays in enrollment in the company's ambulance-based PHAST-TSC phase 2 clinical trial in acute stroke due to the coronavirus. The LA County Fire Department has informed the company, due to the necessity to respond to the pandemic, it is suspending future training of first responders who had been scheduled to participate in the trial protocol. Such disruptions are expected to delay the company's previously announced timeline for study completion. "The coronavirus pandemic is affecting the conduct of clinical trials throughout the world, and the PHAST-TSC program is no exception," said Diffusion's CEO, David Kalergis. "We are following the FDA's recent guidelines for conducting clinical trials during this emergency, and are planning ways to make up lost time once the pandemic abates."

16:10 EDT AAR Corp. to take actions in Q4 to reduce fixed costs - The company stated, "In the fourth quarter, we will be taking actions to reduce our fixed costs and overhead by consolidating facilities with the goal to improve our operating efficiencies. Further, in response to the impact of COVID-19, we have taken actions including reducing executive compensation, freezing new hiring, reducing or eliminating all non-essential spend, furloughs and, unfortunately, reducing our workforce. We expect the cost of these fourth quarter actions to be approximately $15 to $20 million with the payback of these actions realized within one year. We remain prepared to take additional action as warranted to respond to the evolving airline demand environment. Also during the third quarter, we announced multiple new contract wins including: Multiyear distribution agreement with AeroControlex, a large manufacturer of critical components to the aviation industry; Expansion of our airframe maintenance services with Air Canada including plans to add A330 maintenance capability to our operations in Quebec Sole-source Indefinite Delivery/Indefinite Quantity contract award with an estimated value of $90 million from the Defense Logistics Agency Troop Support to produce specialized shipping/storage containers and accessories."

16:09 EDT Square sees trailing 10-day GPV down 25% from last year, withdraws FY20 view - The company states: "Square has been closely monitoring the impact of COVID-19 as the environment evolves. Prior to the impact of COVID-19 in the U.S., Square achieved strong growth during the first two months of the quarter. In January and February, gross profit increased 47% year over year, or 51% year over year excluding Caviar from the 2019 period, driven by momentum across both its Seller and Cash App ecosystems. In January and February, Seller ecosystem gross profit grew 32% year over year, and Cash App ecosystem gross profit grew 118% year over year. Starting in March, the effects of COVID-19 began to impact the company's growth, in particular due to a slowdown in gross processing volume, or GPV, for its Seller ecosystem. While the beginning of March was relatively in-line with the company's expectations, over the trailing ten-day period Seller GPV has declined by approximately 25% year over year, with greater declines in recent days. This has offset relative strength in the Cash App ecosystem, where the impact on gross profit growth has been less pronounced. As a result, Square is revising its growth expectations for the first quarter of 2020 and now expects to report total net revenue in the range of $1.30 to $1.34 billion and gross profit in the range of $515 to $525 million. This range assumes a further deceleration in overall GPV through the last week of March, beyond the levels we have seen in recent days. The company expects to report first quarter 2020 net income (loss) per share, Adjusted EBITDA, and Adjusted EPS that are below the most recent respective guidance ranges provided as of March 5, 2020, following our convertible debt issuance and earnings on February 26, 2020. Given the uncertainty around COVID-19, Square is withdrawing its full-year 2020 guidance and expects to provide a further update on its first quarter 2020 earnings call in May."

16:09 EDT Marchex withdraws Q1 guidance - Marchex announced that due to the growing impact from the COVID-19 outbreak and the resulting uncertainties and disruptions to our customers, at this time the company is withdrawing its previously announced business outlook and financial guidance for the first quarter of 2020 ending March 31, 2020. "We recognize many of our customers are facing unprecedented challenges during this period. As a result, we anticipate that financial difficulties for some of our customers may result in payment delays or impact collectability in the first quarter and immediate future. This may also have a subsequent impact on our near-term results and pipeline as we work closely with our customers to manage through this difficult period," said Russell Horowitz, Executive Chairman and Co-CEO.

16:06 EDT Jones Soda now available nationally at Cracker Barrel locations - Jones Soda announced the launch of new Black Cherry Warhead Jones Soda exclusively at all Cracker Barrel Old Country Stores across the United States.

16:02 EDT Ekso Bionics announces 1-for-15 reverse stock split - Ekso Bionics announced that it will effect a reverse stock split of shares of its common stock at a ratio of 1-for-15, effective as of March 24. The company's common stock will open for trading on The Nasdaq Capital Market on March 25, on a split-adjusted basis under the existing trading symbol "EKSO". The company's common stock will trade under a new CUSIP number 282644301 upon the effectiveness of the reverse stock split. Upon the effectiveness of the reverse stock split, the number of shares of the company's outstanding common stock will decrease from approximately 87.44M pre-split shares to approximately 5.83M post-split shares, with no change in par value per share.

15:35 EDT Ally Financial doubles Carvana loan purchase program to $2B - Carvana (CVNA) announced an increase and extension of its current loan purchase program with Ally Financial (ALLY), which the company said highlights "the deep relationship that has been built between the two companies over the past six years." Ally will provide up to $2.0B of capacity for the purchase of finance receivables over the next 12 months and broaden the set of customers covered by the agreement. "This commitment from Ally puts Carvana in a strong position to provide our customers fair, simple financing in this time when so many need it," said Ernie Garcia, Carvana founder and CEO. "As we work through the current business challenges facing the auto industry, the Ally team remains unwavering in its focus on finding the best solutions to help our dealer customers," said Doug Timmerman, president of Auto Finance for Ally. "We're pleased to have the expertise and agility to deliver a financing agreement that supports Carvana's innovative, digital consumer experience."

15:23 EDT Fulcrum reports complete data from Phase 1 trial with Losmapimod in FSHD - Fulcrum Therapeutics announced complete results from its Phase 1 clinical trial of losmapimod, which is being developed for the treatment of facioscapulohumeral muscular dystrophy, or FSHD. Results were presented by Michelle Mellion, M.D., the Company's senior medical director, in a live Virtual Clinical Trial Session of the Muscular Dystrophy Association Clinical and Scientific Conference. These data support the selection of the 15 mg dose of losmapimod taken orally twice daily in the company's ongoing Phase 2b randomized, double-blind, placebo-controlled 24-week clinical trial, ReDUX4, as well as its Phase 2 open-label study. Both Phase 2 trials completed enrollment in February 2020. Fulcrum plans to hold a separate webcast event in the Spring to discuss the abstracts that were accepted for poster presentation at the Muscular Dystrophy Association meeting which was postponed due to the COVID-19 pandemic. Further details will be announced in the coming weeks, the company said earlier.

15:10 EDT MFA Financial trading resumes

15:00 EDT MFA Financial engaged in talks with financing counterparties on forbearance - MFA Financial announced that in recent weeks the company and its subsidiaries have received an unusually high number of margin calls from financing counterparties, and have also experienced higher funding costs in respect of its repurchase agreements. At the close of business on March 23, 2020, the company did not meet its margin calls. Further, on March 23, 2020, the company notified its financing counterparties that it does not expect to be in a position to fund the anticipated volume of future margin calls under its financing arrangements in the near term as a result of market disruptions created by the COVID-19 pandemic. The company estimates that, as of March 20, 2020, the company's aggregate obligations under its various financing arrangements is approximately $9.5B. "In light of the events and conditions described above, the company is engaged in discussions with its financing counterparties with regard to entering into forbearance agreements pursuant to which each counterparty would agree to forbear from exercising its rights and remedies with respect to an event of default under the applicable financing arrangement for an agreed-upon period. The company cannot predict whether its financing counterparties will enter into a forbearance agreement, the timing of any such agreement, or the terms thereof. Under the terms of the company's financing arrangements, if the company fails to deliver additional collateral or otherwise meet margin calls when due, the counterparties may demand immediate payment by the company of its aggregate outstanding financing obligations and/or take ownership of the securities securing the company's financing obligations," MFA said. The company has engaged Hunton Andrews Kurth LLP and Quinn Emanuel Urquhart & Sullivan, LLP as legal counsel and FTI LLC as financial advisor in connection with its financings and related matters.

14:58 EDT Dollar General announces roughly $35M investment in employees - Dollar General announced its plans to invest approximately $35M in bonuses for all store, distribution center and private fleet employees. Eligible employees include those who perform work during a six-week period beginning in mid-March. Details of the bonuses were shared with employees beginning last week. "Dollar General is proud to have the best team in retail, and the Company's investment in this bonus demonstrates our continued appreciation for all that our employees are doing to serve our customers and communities," said Todd Vasos, Dollar General's CEO. "Throughout our organization, we continue to see our mission of Serving Others on proud display as our employees work diligently to provide our neighbors, friends and communities with the essential products they need at everyday low prices."

14:46 EDT Embraer trading resumes

14:38 EDT FDA alerts of EpiPen auto-injector errors related to malfunctions, user error - FDA is alerting patients, caregivers and health care professionals that EpiPen 0.3mg and EpiPen Jr 0.15mg auto-injectors, and the authorized generic versions, may potentially have delayed injection or be prevented from properly injecting due to: Device failure from spontaneous activation caused by using sideways force to remove the blue safety release; Device failure from inadvertent or spontaneous activation due to a raised blue safety release; Difficulty removing the device from the carrier tube; User errors. In a letter to health care professionals from Pfizer (PFE), the manufacturer of the EpiPen, and Mylan (MYL), detailed how these devices may activate prematurely if the blue safety release is removed using a sideway force, the FDA said.

13:52 EDT MakeMyTrip: Chairman, CEO to take zero salary, effective in April

13:52 EDT MakeMyTrip says 'stellar performance in Q3 was sadly short lived' - Deep Kalra, Group Executive Chairman and Rajesh Magow, Group CEO, shared a message to company employees: "The last few weeks have been very tough for all of us with the sudden and sharp spread of COVID-19 in India. Our stellar performance in Q3 2020 was sadly short lived as the travel and tourism sector is one of the worst sectors that have been hit by this pandemic. There has been sharp drop in bookings with spiralling cancellations and the latest restrictions on domestic air/rail/bus travel has brought our industry to a virtual standstill. The entire country has now been put under lock down for the next three weeks to arrest the spread of this pandemic. These are incredibly tough times that we need to navigate through together! MMYT is known for its resilience, having survived the dot.com bust, 9/11 attacks, SARS epidemic, 2008-09 financial crisis and Indian aviation sector challenges in 2012 and 2019. Economic experts across the world are predicting it to be a global economic tsunami that will have far reaching implications for the global economy. Therefore, we need to focus on two critical areas (i) safety and well-being of our staff, customers and the society at large, and (ii) minimizing the impact to our business from these disruptions. We are reviewing our operating costs and plan to undertake multiple tough measures to keep overall expenses at a minimum. Being an online company, the majority of our costs are variable, however the situation demands that we take a hard look at all our fixed costs including people costs. This means we will continue to sharply reduce variable costs like advertising, sales promotions and payment gateway costs, along with optimizing IT infrastructure and expenses relating to the functioning of our offices and other establishments. We will immediately cancel all discretionary spends such as events, trainings, etc. and also suspend brand building expenses during the following quarter. On people costs front, both of us will take the lead and take zero salary effective April 2020, while the rest of our Leadership Team have also offered to take a reduction of approximately 50% in their compensation. All of the above makes us confident that we would together be able to weather this storm and come out stronger."

13:23 EDT Short-seller calls Reata Pharmaceuticals 'a ticking time bomb' - Reata Pharmaceuticals "might drop over 50% on an imminent regulatory update," according to a Smart Fund report. The authors argue that Reata shareholder shave purchased "a time bomb for their portfolio as success Is assumed, yet unlikely." "A pivotal P3 study of Bardoxolone was halted in 2021 for safety: Bardoxolone didn't reduce progression to end stage renal disease; Bardoxolone was associated with a statistically significant increase in heart failure and a cardiovascular death signal; but showed profound weigh loss. We believe Reata Pharmaceutical subsequently pivoted to rare diseases (lower safety threshold) and aimed to produce false positive efficacy results based on weight loss alone (such as a decline in serum creatinine in Alport Syndrome)," the report reads. In afternoon trading, shares of Reata have gained 6% to $137.Reference Link

13:03 EDT Delta Air Lines rating cut to 'junk' rating of BB from BBB- at S&P - The S&P rating of BB is considered "junk" status.

12:47 EDT Genprex shares rise after bolstering board amid FDA 'fast track' by FDA - Earlier on Tuesday, clinical-stage gene therapy company, Genprex announced the appointment of three new members to its Board of Directors. The new appointments are designed to strengthen the Company as it executes on its key clinical programs, continues to build its pipeline, and evaluates future license or corporate partnership agreements. The new Board members include Brent Longnecker, Chief Executive Officer of Longnecker & Associates, Jose A. Moreno Toscano, Chief Executive Officer of LFB USA Inc, and William R. Wilson, Jr., Chairman, President and Chief Executive Officer of Wilson Land & Cattle. This strengthening of the Board of Directors closely follows the company receiving Fast Track Designation from the Food and Drug Administration, FDA, for its lead drug candidate, raising more than $26 million from institutional investors over the last few months, and licensing a new gene therapy drug candidate for diabetes from the University of Pittsburgh. Also, just yesterday, the Company announced that it strengthened its management team by adding two new senior executives, Catherine Vaczy as Executive Vice President and Chief Strategy Officer, and Michael Redman as Executive Vice President and Chief Operating Officer. "We are honored to have Brent, Jose and Will join our Board in what we believe is a transformational time for our Company," said Rodney Varner, Chief Executive Officer of Genprex. "Their combined experience in regulatory compliance, business development, clinical trial management, and deal structuring will be invaluable as we continue to our develop gene therapy drug candidates and pursue partnerships for our drug candidates. The addition of these outstanding directors, together with our new senior executive hires and a significantly strengthened balance sheet, puts us in an excellent position to execute our plans." Shares of Genprex are up over 7% to $2.43 per share in afternoon trading on Tuesday.

12:40 EDT UnitedHealth offers special enrollment period amid COVID-19 pandemic - UnitedHealthcare announced several updates to its programs in response to the COVID-19 national emergency. In addition to previously announced telehealth and virtual care expansion, the company will open a special enrollment period for some of its existing commercial customers to enable people to get coverage for their health care needs. The company is also further easing administrative requirements to access care through reduced prior authorization requirements. UnitedHealthcare is easing contractual requirements for its fully-insured and level-funded customers to offer a special COVID-19 enrollment opportunity to allow employees who did not opt in for coverage during the regular enrollment period to get coverage. The enrollment period will be open from March 23, 2020, to April 6, 2020. Self-funded customers may choose to amend their eligibility requirements to align with this special enrollment period at their discretion. Customers can contact their broker, consultant or sales representative to speak to them about the special enrollment period. UnitedHealthcare continues to adopt measures that will reduce administrative burden for physicians and facilities to help members more easily access the care they need. This includes: Suspension of prior authorization requirements to a post-acute care setting through May 31, 2020; and suspension of prior authorization requirements when a member transfers to a new provider through May 31, 2020. The company added that it will temporarily suspend or relax additional policies as needed in regions where inpatient capacity is most compromised and most at risk. During this national emergency, UnitedHealthcare will continue to waive cost-sharing for COVID-19 testing provided at approved locations in accordance with the CDC guidelines. In addition, the company will waive cost-sharing for COVID-19 testing related visits, whether the care is received in a physician's office, a telehealth visit, an urgent care center or an emergency department. This coverage applies to commercial, Medicare Advantage and Medicaid members. To increase system access and flexibility when it is needed most, UnitedHealthcare is expanding its telehealth policies to make it easier for people to connect with their health care provider from home.

12:29 EDT MGE Energy amends bylaws to allow for virtual annual meeting - On March 20, 2020, MGE Energy's board of directors approved an amendment to MGE Energy's bylaws to provide the option of holding a virtual annual shareholders meeting in addition to the traditional meeting format in which shareholders attend at a scheduled location.

12:02 EDT Zendesk announces strategic alliance with Tata Consultancy Services - Zendesk announced a strategic alliance with Tata Consultancy Services to provide enterprise grade CRM solutions for large Enterprises. Together, Zendesk and TCS will collaborate and solve companies' increasingly complex technological requirements and provide powerful CRM custom solutions and integrations.

12:01 EDT Sony reduces download speeds for PlayStation Network - Sony Interactive Entertainment president and CEO Jim Ryan said in a blog post that the company is working with internet service providers in Europe to manage download traffic to help preserve access for the entire internet community. "We believe it is important to do our part to address internet stability concerns as an unprecedented number of people are practicing social distancing and are becoming more reliant on internet access," Ryan said. "Players may experience somewhat slower or delayed game downloads but will still enjoy robust gameplay. We appreciate the support and understanding from our community, and their doing their part, as we take these measures in an effort to preserve access for everyone." Reference Link

12:00 EDT Bloom Energy rises 43.0% - Bloom Energy is up 43.0%, or $1.67 to $5.56.

11:55 EDT Cuomo: 'we're not going to sacrifice the 1%-2% for the sake of the economy' - New York Governor Andrew Cuomo said, "sure, only 1%-2% of the population is the risk." Cuomo quoted the arguments being made about halting the economy, "yes, they're old, they're going to die anyway, so why sacrifice the economy for 1%-2% of the population?" Cuomo answered by saying "that isn't the American way and it isn't the NY way." Cuomo said, these aren't just percentages, "they are our parents."

11:50 EDT Microsoft CEO says 'we will weather the storm,' balance sheet strong - Microsoft CEO Satya Nadella said his first focus right now is being the "digital first responder to assist the first responders" and he is confident the company's balance sheet is strong and that Microsoft will be able to "weather the storm" and come out of this global crisis stronger. There has "clearly been a spike in the work from home kit," including PCs, and he is seeing "intense usage" of digital services, Nadella added as he continues being interviewed on CNBC.

11:47 EDT Microsoft CEO says return of workers likely to happen 'in waves,' not on one day - Microsoft CEO Satya Nadella is being interviewed on CNBC.

11:43 EDT Microsoft CEO says Teams has 'become critical infrastructure' for work from home - Nadela says the scale of the current situation is "unprecedented" and current SAAS, public cloud and data-center architectures have been able to scale to meet "peak demand." Microsoft CEO Satya Nadella is being interviewed on CNBC to discuss the company's role in combating COVID-19.

11:27 EDT NYS Governor Cuomo: FEMA 'missing the magnitude of the problem' - New York Governor Andrew Cuomo said FEMA is sending 400 ventilators to NY, "but we need 30,000." Cuomo added FEMA is "missing the magnitude of the problem."

11:21 EDT NYS Governor Cuomo: 'no American is going to put the economy over human life'

11:19 EDT Intel suspends stock repurchases amid COVID-19 pandemic - In an filing with the SEC, the company said, "On March 24, 2020, Intel announced that it is suspending stock repurchases in light of the COVID-19 pandemic. To date, Intel has kept its factories operational while safeguarding the health and safety of employees and continues to have a strong balance sheet. Intel's management believes the suspension, while conservative, is prudent given uncertainty regarding the length and severity of the pandemic. The suspension of stock repurchases will not impact dividend payments to stockholders and the company has the ability to reinstate repurchases as circumstances warrant. In October 2019, Intel announced its intention to repurchase $20B in shares over the next 15 to 18 months. Intel has repurchased a total of approximately $7.6B in shares in the fourth quarter of 2019 and first quarter of 2020, prior to the suspension."

11:16 EDT Marriott CEO seeing business activity beginning to step back up in China

11:12 EDT Loop Energy announces additional cash investment from Cummins - Loop Energy announced that the Company has received an additional cash investment from Cummins. The further investment was made following Loop's successful completion of milestone requirements established at the time of Cummins initial investment in September 2019. Funds from the strategic financing will be used to further accelerate the company's product development activities, project deployments, and growth plans as the Company expands its technical leadership in medium and heavy-duty hydrogen fuel cell bus and trucking applications.

11:07 EDT Fuling Global resumes full production at manufacturing facilities in China - Fuling Global announced that production at its three manufacturing facilities in China have resumed to 100% capacity. Xinfu Hu, CEO of Fuling Global, said, "We began chartering flights and buses to return non-local employees since early February, and are happy to report that we have cautiously, steadily and successfully ramped up since, with production back in full force to ensure that our customers' purchase orders can be fulfilled. All of our facilities throughout the globe have implemented additional safety measures to prevent contamination from COVID-19. We will continue to closely monitor the situation to ensure we are taking every precaution and all appropriate steps to maintain a safe and healthy environment for our workforce."

11:06 EDT Keysight Technologies says DEKRA selects 5G test solutions - Keysight Technologies announced that DEKRA has selected Keysight's end-to-end test solutions to certify 5G new radio and vehicle-to-everything devices, in compliance with a wide range of requirements, to improve safety in human interaction with technology, including vehicles. DEKRA recently announced that the company plans to extend its services for testing and certifying the performance and safety of 5G devices according to 3GPP and regulatory standards. Keysight's 5G test solutions allow test labs such as DEKRA validate devices equipped with 5G NR connectivity, in compliance with standards organizations and regulatory bodies such as 3GPP, the Federal Communications Commission and ETSI. Keysight's solutions support a leading number of test cases mandated by GCF and PTCRB for radio frequency, radio resource management and protocol testing.

11:05 EDT KeHE Distributors parnters with Clean Energy for low-carbon emission trucks - KeHE Distributors has partnered with Clean Energy Fuels to add low-carbon emission trucks fueled with renewable natural gas to their California fleet in 2020. By swapping five diesel trucks with natural gas trucks, KeHE expects an annual carbon reduction of 674 metric tons, the equivalent of planting 11,120 trees and recycling 235 tons of landfill waste. Clean Energy's Redeem RNG is a clean low-carbon alternative fuel produced from organic waste. The environmentally friendly fuel source has been proven to reduce greenhouse gas emissions by at least 70% versus diesel. Zero Now is an ultra-clean fuel and engine combination, developed by Clean Energy, to help achieve zero emissions in the trucking industry.

10:49 EDT Ford reassessing timing for resuming vehicle production in North America - Kumar Galhotra, Ford's president of North America, issued the following statement:" Ford's top priority is the health and safety of our employees, dealers, customers, suppliers and other stakeholders. In light of various governments' orders to stay and work from home, Ford is not planning to restart our plants in the U.S., Canada and Mexico on Monday, March 30 as originally hoped. We are assessing various options and working with union leaders - including the United Auto Workers and Unifor - on the optimal timing for resuming vehicle production, keeping the well-being of our workforce top of mind. We will provide additional updates as details are confirmed."

10:34 EDT Fresh Del Monte to deliver uninterrupted supply of fruits, vegetables - Fresh Del Monte Produce announced that during the COVID-19 pandemic it would continue to deliver an uninterrupted supply of fresh fruits and vegetables. Fresh Del Monte Produce has taken numerous steps to date aimed at navigating this challenging global situation, supporting its employees, and ensuring business continuity: Since the emergence of the COVID-19, Fresh Del Monte Produce has activated its Global Executive Crisis Management team and regional response teams so that it can continuously stay abreast of the situation and communicate the latest developments, proactively monitoring and adjusting business processes and procedures as necessary to ensure business continuity. Fresh Del Monte Produce production facilities remain open in those locations where permitted. To increase social distancing, steps have been taken to reduce the number of employees in farm locations, packing houses, port operations and production facilities, while ensuring business continuity. In addition to strict good manufacturing policies, Fresh Del Monte Produce has increased its cleaning cycles in its facilities, protecting against pathogen cross-contamination and worker-to-worker spread. These include monitored handwashing practices and sanitization requirements. Any employees showing signs of illness are immediately segregated from the workforce and monitored before being allowed to return. Although these practices were in place already as regular practice, they have been instrumental in helping mitigate the spread of COVID-19. Fresh Del Monte Produce has activated its supply chain contingency plans to avoid any ongoing disruptions with respect to the company's ability to service its customers.

10:30 EDT Marine Products trading halted, volatility trading pause

10:27 EDT Coca-Cola CEO says will see a financial impact in Q2 - In an interview with CNBC, Coca-Cola CEO James Quincey said the at home is not going to compensate from the away from home business, especially in a hard lockdown. He added that the company has a lot of levers to rebalance the business, including marketing and using its capital.

10:24 EDT Coca-Cola CEO has no plans to launch job restructuring for employees - In an interview with CNBC, Coca-Cola CEO James Quincey said the company has not, and has no plans to look at job restructuring. He added that he does not want to lose his skilled employees.

10:09 EDT Yamana Gold to work with Quebec government in relation to Canadian Malartic - YAMANA GOLD provides the following update on its Canadian Malartic operation in response to an order of the Government of Quebec in relation to COVID-19 to temporarily suspend all non-essential business until April 13, 2020. Mining has been listed as one of the priority services and activities with minimized activities. The Company intends to work with the Quebec government to comply with the order in relation to Canadian Malartic. Any further impact to operations, which may include suspension of operations or placing the mine on care and maintenance, will be updated in due course. The operation is in close communication with local communities and its workforce to apprise them of the situation and assure them that all safety and environmental protocols and procedures will be followed. There are currently no suspected or confirmed cases of COVID-19 at Canadian Malartic or any Yamana operation. The Company continues to take every precaution to ensure the safety of its employees, families, and communities, and it is working closely with its host communities to support their needs through this difficult period.

10:08 EDT Vuzix receives follow-on smart glasses order from 1Minuut Innovation - Vuzix Corporation announced the Company has received a follow-on M400 Smart Glasses order from 1Minuut Innovation, a Dutch medical services company. This follow-on order for 110 M400 Smart Glasses with accessories represents ongoing business demand from 1Minuut beyond a previously announced shipment of over 100 M400 Smart Glasses. Intended usage for these units is for general telemedicine and to support 1Minuut Innovation in response to COVID-19 healthcare needs in the Netherlands.

10:06 EDT People's United to waive fees on a case-by-case basis - People's United Bank announced support and relief initiatives for customers, communities, and businesses experiencing hardship as a result of COVID-19 that may include loss of work and business revenue, or increased requests for non-profit aid. People's United's COVID-19 support and relief initiatives include: Waiver of Fees: On a case-by-case basis for late/overdraft, ATM fees, CD penalty waivers, and postponement of some planned fee changes for April 1, 2020. Consumer Loans: Individualized support is available, which includes a 90-day foreclosure moratorium on eligible residential loans for customers who may need it. Customers should contact People's United's loss mitigation team to discuss repayment and forbearance support at 1 (800) 463-0416. Business Loans: Individualized support is available for clients who may need it. Clients should contact their relationship manager or local branch directly to discuss. Business Credit Card: Offering extended payment terms and waiving associated fees from April 1 to May 31. SBA, State, Municipal Support: Access to government enacted SBA emergency loans and curated educational resources, as well as state or municipal loan programs for customers seeking assistance. Community Support: Actively engaging with community organizations and government officials to ensure a coordinated approach that complements national, state, and local relief efforts. Monetary support will be provided to response funds and non-profits who are meeting the basic needs of vulnerable populations, including low-income residents, first responders, healthcare workers, and small businesses. In addition, People's United has implemented a prevention and social distancing protocol company-wide that includes a remote-enabled workforce where possible, and additional paid-time-off for those who are unable to work remotely. The Bank has also augmented branch service, including reduced hours and appointment-only banking, limiting foot-traffic, and focusing on serving customers through the Bank's digital and online channels, ATMs, drive-ups, and phone banking, from which customers can conduct many of the same transactions as they would in a branch.

10:02 EDT HP Inc. says mobilizing 3D printing solutions to battle COVID-19 - HP Inc. and its global digital manufacturing community are "mobilizing their 3D printing teams, technology, experience, and production capacity to help deliver critical parts in the effort to battle the COVID-19 pandemic," the company announced. More than 1000 3D printed parts have already been delivered to local hospitals and HP's 3D R&D centers in Barcelona, Spain; Corvallis, Oregon; San Diego, California; and Vancouver, Washington are collaborating with partners around the world in a coordinated effort to increase production to meet the most urgent needs, the company noted. Initial applications being validated and finalized for industrial production include face masks, face shields, mask adjusters, nasal swabs, hands-free door openers, and respirator parts. HP is also coordinating with government, health, and industry agencies in numerous countries to ensure a synchronized and effective approach, the company stated.

10:00 EDT ProShares Trust Ultra VIX Short Term Futures ETF falls -31.6% - ProShares Trust Ultra VIX Short Term Futures ETF is down -31.6%, or -$22.13 to $47.80.

10:00 EDT Invesco Mortgage falls -40.8% - Invesco Mortgage is down -40.8%, or -$2.18 to $3.15.

10:00 EDT Direxion Daily Jr Gld Mnrs Bull 3X Shrs rises 27.8% - Direxion Daily Jr Gld Mnrs Bull 3X Shrs is up 27.8%, or $1.11 to $5.11.

10:00 EDT Hudson rises 27.9% - Hudson is up 27.9%, or $1.07 to $4.90.

09:50 EDT Seneca Foods trading resumes

09:49 EDT Satsuma Pharmaceuticals Inc trading resumes

09:47 EDT Verrica Parmaceuticals Inc trading resumes

09:47 EDT Direxion Daily Gold Miners Bear 3X ETF falls -32.0% - Direxion Daily Gold Miners Bear 3X ETF is down -32.0%, or -$1.53 to $3.25.

09:47 EDT Spirit Airlines rises 20.0% - Spirit Airlines is up 20.0%, or $1.97 to $11.80.

09:47 EDT Broadmark Realty Capital rises 33.2% - Broadmark Realty Capital is up 33.2%, or $1.93 to $7.75.

09:45 EDT Siebert Financial trading resumes

09:45 EDT Seneca Foods trading halted, volatility trading pause

09:45 EDT Cinemark trading halted, volatility trading pause

09:44 EDT Fluor trading resumes

09:43 EDT Milestone Pharmaceuticals Inc trading resumes

09:42 EDT Brighthouse Financial trading resumes

09:41 EDT Spirit AeroSystems trading resumes

09:41 EDT Moderna trading halted, volatility trading pause

09:40 EDT Siebert Financial trading halted, volatility trading pause

09:39 EDT Caesars trading halted, volatility trading pause

09:39 EDT Fluor trading halted, volatility trading pause

09:39 EDT Milestone Pharmaceuticals Inc trading halted, volatility trading pause

09:38 EDT Discovery Communications trading resumes

09:38 EDT Copa Holdings trading resumes

09:37 EDT 180 Degree Capital says 'well-equipped' to weather storm of COVID-19 - 180 Degree Capital Corp. published a letter to shareholders, which read in part, "In the near term, Let me offer a few thoughts on what we have been doing and some general views we have of our company. Other than one person, which for now happens to be me, we are all working from home and communicating as frequently as we would if we were all in the office together. In fact, the lessons of 9/11 prompted Wall Street to make it possible to be fully functioning at home. Bloomberg Terminals work from anywhere, and we have the ability to trade without limitations no matter where we are physically located. If you add in text, email, video conferencing, and cell phones, communication is free flowing. It is important to remember that TURN has permanent capital. While other funds have to sell due to redemptions or other factors, we do not. We started the year with $51 million in cash and public company securities, and $12 million of that amount in cash. As you can imagine, we have been adding to certain select names. The adds, however, have been on the margin. We mentioned COVID-19 as a risk in our fourth quarter letter and we have waited a bit to add to our equity exposure. Today, our cash position is more than 10% of our combined cash and public company securities. This meltdown is real, and the economic ramifications of worldwide quarantines are yet to be fully felt. During this time, we are less preoccupied with TURN's stock price and what our transitory book value is going to be at the end of this quarter. There is no doubt in my mind that this wipeout will end with companies going out of business. We have spent the last few weeks stress testing our financial models for each of our holdings for potential revenue declines of 50 percent or more for a period of quarters. We're actively assessing what each of our holdings have to do on the cost side to conserve cash, protect its balance sheets, and get to the other side of this crisis. As a general overview, the majority of our holdings do not have significant or outsized financial leverage. Many have net cash. But like the rest of the world, they have the uncertainty of a complete collapse in their revenues. Just because a company isn't tripping debt covenants doesn't mean that the company won't face a cash crunch. We have been spending time with our holdings, hearing their action plans for this crisis and providing our perspectives on these plans. We are stress testing our own models to assess how long a company can survive this downturn. We have told every one of our companies that their job right now is to: 1) preserve cash and protect the balance sheet, and 2) challenge themselves to learn how to operate and survive with revenues down 50 percent. As one very smart friend of mine told me, "you aren't serving your employees if you drive the bus off the cliff." You have entrusted us with your investment in TURN, and we entrust management teams with TURN's capital. We expect our management teams to maneuver through changing environments. Our companies are not going to sit on their hands and do nothing. They are going to proactively manage their business. Nothing is static. We like our holdings, we like our management teams, and we expect them to do whatever is necessary to ensure viability. Although I am certainty not a Pollyannaish person, I do think we have a good collection of assets. If we felt otherwise, we would sell and move on. On the private side, one can also expect some degree of dislocation as many of our holdings rely on continuous funding to keep going. Our board of directors formally values our private holdings at the end of each quarter. That said, based on the information available as of the date of this letter, we currently estimate that potential writedowns of the private portfolio equate to roughly half of the decline Russell Microcap Index on a relative percentage basis. As for where our NAV shakes out this quarter, first let me say the quarter still has a few more days left. We usually spend the first few days after the quarter has ended going through our formal process for valuing the private portfolio. My point is all of this can change for the better, or for the worse. Our public portfolio companies have thus far performed better than the indices and we currently estimate that our private portfolio has performed better than our public portfolio. These two data points mean that we currently believe our NAV has not declined by the same 40% decline of the Russell Microcap Index or the 44% decline of the Russell Microcap Value Index. And yet, our stock price has collapsed by 48% to a lower price than what it was when we took over an incredibly broken Harris & Harris Group. As for our own stock price, I am deeply disappointed by the decline, although I understand the indiscriminate selling that comes with redemptions and margin calls. Clearly, I think the valuation is absurd. Our management team bought stock today in addition to multiple purchases throughout March. We will continue to add to it as we are now nearly trading at our cash and public holdings. We are not thinking about where our share price will be in a week, but rather do we think it can be materially higher sometime down the road."

09:37 EDT Spirit AeroSystems trading halted, volatility trading pause

09:36 EDT IHS Markit trading resumes

09:35 EDT Apple Hospitality REIT trading resumes

09:35 EDT Vapotherm Inc trading resumes

09:34 EDT SiTime Corporation trading halted, volatility trading pause

09:33 EDT First Bancorp trading halted, volatility trading pause

09:33 EDT Deckers Brands resumes operations with limited capacity at Moreno Valley center - Deckers Brands announced an update to the actions the Company is taking in response to COVID-19. As Deckers Brands continues to review expert agency guidelines, paired with information from local authorities, the Company has implemented additional precautionary measures and social distancing procedures at its distribution center located in Moreno Valley, California. After instituting these enhanced safety protocols, Deckers Brands has resumed modified operations with limited capacity at the distribution center. The Company will continue to assess the appropriate scope of operations and allocation of resources within this facility, as well as others, in response to the dynamic business environment. The Company will continue to monitor this fluid situation and expects to continue to evolve its operations to react to the challenges of COVID-19 as deemed necessary.

09:32 EDT Brighthouse Financial trading halted, volatility trading pause

09:30 EDT IHS Markit trading halted, volatility trading pause

09:30 EDT Vapotherm Inc trading halted, volatility trading pause

09:29 EDT Triumph Group announces measures including elimination of 250 positions - Triumph Group provided an update on the current impact of the coronavirus, or COVID-19, on the business and the steps the Company is taking to mitigate it. The Company is expanding its actions to limit the spread of COVID-19 consistent with U.S. and international government safeguards. Although the situation remains fluid, all factories remain operational. Triumph is complying with all mandates for closure of non-essential operations. Given Boeing's plans to close their Washington state factories for 14 days, Triumph will evaluate the need to furlough employees at a subset of Triumph plants where capacity is largely dedicated to Boeing Commercial Aircraft programs. Regarding the Company's plans to respond to the COVID-19 crisis, and to conserve cash and maintain long-term competitiveness, the following actions are underway: approximately 250 full-time salaried employee and 250 contractor positions will be eliminated. Severance will be paid to impacted employees consistent with existing policies. These reductions are expected to be completed by May 1. The Company will implement furloughs for certain salaried employees of two weeks over fiscal 2021 to minimize reductions in force. Additional furloughs may be required based on site closures or reductions in customer demand for Triumph's products and services. Base salaries and wages for hourly and most salaried employees will be maintained. Medical benefits will continue during furloughs. Triumph will suspend merit pay increases for all team members until the crisis has passed while forgoing management increases for one year. Senior executives, including the CEO and direct reports, will forgo 10% of their base salaries starting April 1 during the crisis. Triumph's Board of Directors has elected to reduce their cash compensation during the crisis by 25%. The Board will continue to adjust executive and Director compensation as the situation warrants.

09:24 EDT Agnico Eagle provides update after COVID-19 quarantine measures in Quebec - Agnico Eagle Mines provides an update following yesterday afternoon's order by the Government of Quebec to close all non-essential businesses relating to COVID-19. Pursuant to this order, mining operations have been directed to minimize their activities until April 13. The Company is communicating with the Government of Quebec to ensure compliance with its order and will discuss procedures at the Company's Quebec operations while having regard to the health and safety of our employees and communities. Any impact to operations or production guidance, which may include the suspension of mining activities at the Company's operations in the Abitibi region of Quebec and moving to care and maintenance until April 13, 2020, will be provided to the market in due course.

09:19 EDT First Quantum Minerals reports $523M in net unrestricted cash at Dec. 31 - The Company had $523 million in net unrestricted cash at December 31, 2019. Following the successful bond issuance in January 2020, the Company repaid the senior Revolving Credit Facility resulting in approximately $700 million available in undrawn committed credit facilities and no near term debt maturities following the repayment of the remaining outstanding bonds due February 2021 giving the Company a total of $1.2 billion in pro-forma cash and available credit. Additionally, the Company has mitigated some of the copper price volatility in the near term with a solid copper hedge position of 343,025 tonnes of copper sales to January 2021 using both unmargined copper forward sales and unmargined zero cost collar sales contracts. 174,700 tonnes in Q2 are currently hedged at an average floor price of $2.61 per pound, 75,825 tonnes in Q3 are hedged at an average floor price of $2.62 per pound, and 60,000 tonnes in Q4 are hedged at an average floor of $2.66 per pound. The Company also has 4,183 tonnes of nickel in H1 2020 hedged at an average floor price of $6.78 per pound and 5,938 tonnes of nickel in H2 2020 hedged at an average floor price of $6.76 per pound. The commitment to deleveraging the balance sheet remains and a plan is in place to deleverage and manage debt in the current commodity price environment. "We remain committed to deliver growth in copper production at low costs and to de-lever our balance sheet," stated Philip Pascall, CEO. "These times are unprecedented, they require adaptability and flexibility which are part of the culture we've built at First Quantum. We are well positioned to execute our plans through this period of uncertainty and continue to believe in the long-term fundamentals of copper."

09:18 EDT First Quantum Minerals reaffirms production, cost expectation guidance - The company said, "The Company has not experienced any significant disruption to sales, supply chains and product shipments since the onset of the COVID-19 pandemic. The Company's production and cost expectations as previously guided remain current. Year-to-date operations in Zambia have been slightly better than expected with good grades and recoveries within the mixed and sulphide ores at Kansanshi and improved mining volumes and ore grades at Sentinel. Following the announcement of heightened restrictions in South Africa, including controls on ports and transit routes, the Company is managing the export of its Zambian production through alternate routes. Cobre Panama continues to ramp-up and expectations for 2020 copper production remain unchanged at 285,000 - 310,000 tonnes. However, as a result of the implementation of the health protocols at the operation, the pace of ramp-up may be slightly slower than originally planned and will impact first half production. At this stage, it is expected that the annual production expectation can still be met with better than planned second half production levels. The Punta Rincon international port at Cobre Panama remains open for import and export. The restart of operations at Ravensthorpe has continued with the first shipment expected to be within the first half of the year. At Las Cruces in Spain, the focus is on mining out the remaining in-pit ore which is progressing to plan. All other operations are operating normally. "

09:17 EDT First Quantum says several members of contract workforce confirmed with COVID-19 - "Our key priorities are the health of our employees and to ensure the business remains robust in the midst of a challenging commodity price environment," stated Philip Pascall, CEO. "We are doing everything we can to care for our staff, their families and the communities around us in relation to the COVID-19 pandemic. It is also our responsibility that we continue our contribution to the economies of the countries in which we operate and supply the products on which our customers depend. We will continue to operate our mines responsibly, providing employment and generating revenues, and we will ensure that our business withstands this period of downturn." The company said, "Several members of the contractor workforce at the Cobre Panama operation have been confirmed as having contracted the COVID-19 virus. The affected personnel are being cared for in the public healthcare system as per the Panama Ministry of Health requirements. Cobre Panama has already implemented the appropriate control, isolation and quarantine measures in line with Government guidelines and its site-specific conditions. On Friday March 20, the Government of Panama by means of Executive Decree 500 clarified that Cobre Panama is specifically authorized to continue operating, albeit with strict adherence to the protocols established by the Ministry of Health which will require a reduced labour force operating on 12 hour shifts. Similarly, on other mine sites the Company is prepared for control, isolation and quarantine as necessary. As more countries take action to manage and mitigate the impact of COVID-19, First Quantum is managing the necessary country-by-country restrictions in order to assist in the protection of those most vulnerable.:

09:14 EDT Akers Biosciences acquires licenses to coronavirus vaccine candidate - Akers Biosciences announced that it has acquired a licensing agreement with Premas Biotech, under which Akers will in-license a novel coronavirus vaccine candidate under development by Premas using Premas' genetically engineered S. cerevisiae platform, D-Crypt, and partner with Premas to ultimately seek FDA approval. The current global crisis has created the potential for an expedited review process from the FDA, which has recently noted its willingness to fast-track human clinical trials for certain coronavirus candidates. Premas is utilizing its D-Crypt platform to recombinantly express the major structural proteins of the coronavirus. Based on genetically engineered baker's yeast S. cerevisiae, D-Crypt is highly scalable into commercial production quantities and has been previously utilized for the production of multiple human and animal health vaccines candidates during its 10-year development track record. Under the terms of the agreement, Akers is acquiring Cystron Biotech LLC for a $1M upfront payment, 622,756 shares of common stock or common stock equivalents and a royalty on net sales. In addition, Akers shall make additional payments of cash and stock to the sellers of Cystron Biotech LLC upon the achievement of certain milestones, along with a change of control. Akers is also required to make certain cash payments to Premas upon the achievement of additional milestones. For a more detailed description of the transaction documents, please see Akers' Current Report on Form 8-K, filed with the U.S. Securities and Exchange Commission on March 24, 2020.

09:13 EDT Starbucks CEO says learned COVID-19 'playbook' over nine weeks in China - Starbucks CEO Kevin Johnson said the company learned the COVID-19 "playbook" over nine weeks of dealing with the disease in China, adding "we're on the uptick in China." Johnson is being interviewed on CNBC.

09:11 EDT Quantum Computing announces technology partnership with Splunk - Quantum Computing has entered into a Technology Alliance Partnership agreement with Splunk.Splunk turns data into doing with the "Data-to-Everything" Platform. Splunk technology is designed to investigate, monitor, analyze and act on data at any scale, from any source over any time period. QCI will partner with Splunk to do both fundamental and applied research and develop analytics that exploit conventional large-data cybersecurity stores and data-analytics workflows, combined with quantum-ready graph and constrained-optimization algorithms. These algorithms will initially be developed using QCI's Mukai software platform, which enables quantum-ready algorithms to execute on classical hardware and also to run without modification on QC hardware when ready. Once proofs of concept are completed, QCI and Splunk will develop new analytics with these algorithms in the Splunk data-analytics platform, to evaluate quantum analytics readiness on real-world data. The Splunk platform/toolkits help customers address challenging analytical problems via neural nets or custom algorithms, extensible to Deep Learning frameworks through an open source approach that incorporates existing and custom libraries. The initial efforts of our partnership with Splunk will focus on three key challenges: network security, dynamic logistics and scheduling.

09:10 EDT ICF International provided update on impact of COVID-19 - ICF provided an update on the current impact of COVID-19 on its business. John Wasson, president and CEO, stated "It is too early to say with any certainty what the specific impacts on ICF may be from this unprecedented health crisis. We have implemented work from home protocols across the company to protect our staff, give them flexibility to deal with the closure of schools and day care facilities, and comply with shelter in place requirements in certain localities. Our staff are experienced in working from home, and we are pleased that we are effectively transitioning to serve clients through teleworking. From a business perspective, thus far we are experiencing continuity in the vast majority of our work for government clients, which accounted for approximately 65 percent of our revenues in 2019." And ended, "Lastly, ICF has a very strong culture, great people, loyal clients and an experienced management team, and we have been through volatile periods before, including government shutdowns and the 2008 financial crisis."

09:08 EDT Bank of Marin temporarily suspends share repurchase program - Bank of Marin Bancorp announced a decision made by its board on March 20 to suspend its share repurchase program indefinitely. "This is not a cancellation of our share repurchase program but a precautionary suspension in response to the ongoing COVID-19 pandemic," said Brian Sobel, Chairman of the Board. "We will monitor the situation closely and reinstitute the program when the Board believes it is appropriate. Bank of Marin's current capital position remains strong." On January 24, the Bancorp board approved a Share Repurchase Program under which Bancorp may repurchase up to $25 million of its outstanding common stock through February 28, 2022.

09:07 EDT Air Products signs new contract with Techpack Solutions - Air Products announced it has signed a new contract for its integrated oxy-fuel combustion solution with Techpack Solutions, the largest packaging materials manufacturer in South Korea. It is Air Products' third project to support Techpack Solutions to convert its furnace from air-fuel to oxy-fuel for enhanced sustainability and competitiveness. When the project comes onstream, Air Products will supply the oxygen and combustion systems required by Teckpack Solutions at its manufacturing complex. The integrated solution encompasses Air Products' advanced oxy-fuel combustion system, including the Cleanfire HRiTM and latest Cleanfire HRxTM oxy-fuel burners and an automatic flow control skid, as well as a PRISM vacuum swing adsorption oxygen generator to supply reliable and economical on-site oxygen used to power the oxy-fuel burners for melting glass.

09:07 EDT Glaukos provides COVID-19 update, withdraws Q1, FY20 guidance - Glaukos provided an update on the actions it is taking in response to the COVID-19 pandemic. In order to prioritize the health and safety of employees, healthcare professionals, patients and its communities, while continuing to support its customers, Glaukos has acted quickly in recent weeks to implement a number of measures: Health and Safety: In a continuing effort to take steps to protect the health and safety of our workforce and their families and communities, and based on applicable orders and recommendations from federal and local government and health agencies, all employees, with the exception noted below, have been required to work from home. The company has also implemented other measures, such as restricting travel, to protect the health and safety of our customers, their patients and our employees. Maintaining Operations: Consistent with applicable exceptions, Glaukos is maintaining streamlined manufacturing, assembly and other related processes at this time in order to continue providing products to our customers. Glaukos employees involved in such operation-critical processes are organized into a number of small shifts designed to minimize the time any one individual is required to be onsite. For these employees, we have implemented a number of other recommended best practices to protect the health and safety of our workforce. "Our hearts go out to anyone affected by the virus and we are especially grateful for the healthcare providers who are selflessly caring for those who are ill. During these challenging times, our first priority is the health and safety of our employees, customers, patients, providers and the communities in which we operate," said Thomas Burns, Glaukos president and chief executive officer. "While our business may be materially impacted over the short-term as procedures may be temporarily deferred in countries and regions impacted by the COVID-19 outbreak, we have acted proactively to implement several initiatives to best preserve our near-term and future growth opportunities, support our customers and reduce non-essential discretionary spending. These initiatives, paired with our strong current financial position, leave us well-positioned to ultimately provide our essential ophthalmic therapies to customers and their patients who will return for treatment as we move past the peak of this current crisis. I am confident that the longer-term fundamental prospects of our business remain strong and unchanged as we advance our mission to transform the treatment of chronic eye diseases with novel therapies that provide sustainable solutions to important clinical needs." As of December 31, 2019, Glaukos had approximately $183 million in cash and cash equivalents, short-term investments and restricted cash. Additionally, the company does not carry any outstanding debt obligations. Due to the rapidly evolving environment and continued uncertainties from the impact of COVID-19, Glaukos is withdrawing its previously announced first quarter and annual guidance for 2020, which was issued on February 27, 2020. At this date, Glaukos cannot predict the specific extent, or duration, of the impact of the COVID-19 outbreak on its financial and operating results. Glaukos plans to provide additional information, to the extent practicable, during its first quarter earnings call in May.

09:05 EDT Simpson Manufacturing provides corporate update - Simpson Manufacturing provided a corporate update in response to the COVID-19 pandemic. The Company continues to evaluate the global risks to public health and the slowdown in business activity related to the COVID-19 pandemic, including the potential impacts on its employees, customers, suppliers and financial results. As the situation surrounding COVID-19 remains fluid, it is difficult to predict the duration of the pandemic and its impact on the Company's business, operations and financial condition. As previously disclosed, the Company is a borrower and certain of its domestic subsidiaries are guarantors under a credit agreement, which provides the Company with a $300M revolving credit facility that expires in July 2021. As a prudent measure, the Company elected to draw down $150M from the Credit Facility in order to increase its cash position and preserve financial flexibility in light of current uncertainty resulting from the COVID-19 outbreak. After the draw down, the Company expects to have approximately $300M of cash on hand and approximately $150M remaining under the Credit Facility. As a result of the COVID-19 pandemic, the location of the Company's 2020 annual meeting of stockholders has been changed and will be held in a virtual meeting format only.

09:04 EDT Opko Health's BioReference Labs, City of Miami to provide COVID-19 testing - BioReference Laboratories, an OPKO Health company, announced a collaboration with the City of Miami to provide COVID-19 testing. BioReference will provide COVID-19 testing at drive-through locations for Miami residents by appointment. BioReference is also announcing that they are providing testing for drive-through testing centers in South Florida, Hialeah and Hollywood through a collaboration with Larkin Community Hospital.

09:02 EDT eXp Realty introduces telemedicine plan for eXp AgentsTeladoc - eXp Realty (EXPI) announced it is offering a telemedicine plan for all U.S. eXp Realty agents as part of eXp Agent Healthcare and in partnership with Clearwater Benefits. Telemedicine subscriptions are typically only available through employer and group insurance plans, but this solution provides no-copay access to virtual primary care to all U.S. eXp agents and their families for the lowest monthly rate on the market. Agents do not have to hold health insurance through eXp Agent Healthcare to enroll in the plan. Now, every U.S. eXp Realty agent can sign up for a discounted telemedicine solution starting at $9 per month for their whole family, including parents or other adult family members. Plan members also can request a three-way visit with a family member and the medical provider. The telemedicine plan is through Teladoc (TDOC), the global leader in virtual healthcare. Agents receive service via videoconference with no copay, unlimited visits and 24/7 access to more than 50,000 physicians. Currently, the average response time to talk to a board-certified physician via Teladoc is hours compared to days or longer for an in-person appointment. Access to additional specialists such as dermatology and mental health providers are available for a low copay.

09:02 EDT HomeStreet suspends share repurchase program - HomeStreet announced that it has suspended its current share repurchase program, which had been authorized by the board and not objected to by regulators for up to $25 million in aggregate amount of its common stock, no par value, and separately of its intention to withdraw its request for non objection of a subsequent increased authorization of up to an additional $10 million in aggregate amount of shares of the company's common stock. As of the close of business on March 19, the last day before the company suspended the share repurchase plan, HomeStreet had repurchased 335,360 shares under the current plan at an aggregate cost of approximately $7.9 million.

09:00 EDT Aethlon Medical receives European patent for its Hemopurifier technology - Aethlon Medical announced that it has received European Patent No. 1,993,600 entitled "Extracorporeal Removal of Microvesicular Particles." The '600 patent embodies Aethlon's Hemopurifier technology designed for the depletion of immune suppressive, and potentially cancer-promoting, exosomes from the circulatory system. Exosomes have been shown to participate in the development and advancement of cancer. Exosomes derived from tumor cells may promote immune suppression and seed the spread of metastasis. Notably, these tumor derived exosomes may also inhibit the activity of immuno-oncology drugs such as pembrolizumab.

08:58 EDT MasterCard provides update regarding COVID-19, suspends FY20 outlook - We have been closely monitoring the impact of COVID-19 and our thoughts are with the individuals and families whose lives have been affected by the spread of the virus. In these unprecedented times, our top priority is to ensure the health and safety of our employees and support those in need. We have taken several actions to protect our employees, including asking many employees to work from home, establishing split working schedules, restricting business travel and creating a special paid leave program for those impacted by COVID-19. We are also supporting those affected by the virus in many ways, including participating in efforts to accelerate the development of, and access to, treatment for COVID-19 and programs such as employee donation matching for relief efforts. Our operations continue to be supported by a resilient core infrastructure and comprehensive business continuity plans. As the impact of the virus has rapidly expanded around the globe, we have seen further deterioration in our cross-border, switched volume and switched transaction metrics, although revenue related to our services lines has held up reasonably well. As a result, we are making the following updates to our first quarter year-over-year growth rates for both net revenue and operating expenses, on a non-GAAP, currency-neutral basis, excluding acquisitions. On this basis, we now expect: First quarter growth in net revenue in the low-single-digits range. We have also seen some shifts in foreign exchange rates and anticipate that the currency impact will be about a 2 percentage point headwind to net revenue growth in the first quarter. First quarter growth in operating expenses in the low-to-mid-single-digits range. In response to the COVID-19 situation, we are taking several actions to manage our expenses prudently, including evaluating our travel & entertainment, advertising & marketing and professional fees spending starting this quarter, all while ensuring that we invest in the long-term growth of our business. We expect operating expense savings to ramp as we move forward. The long-term fundamentals of our business remain strong. However, due to the speed with which the COVID-19 situation is developing and the unknown duration and severity of the event, we are suspending our annual 2020 outlook for both net revenue and operating expense growth at this time. We anticipate giving further updates on our first-quarter earnings call.

08:53 EDT Telguard receives NYC certificate of approval for fire alarm communicator - Telguard announced that its cellular fire alarm communicators have been issued a Certificate of Approval, #6316. This means Fire & Life Safety dealers in New York City are now able to use Telguard's premier cellular fire communicator, the TG-7FS LTE.

08:52 EDT Kodiak Sciences receives full registration of its trademarks - Kodiak Sciences announced that the company received full registration of their trademarks "Kodiak" and "Kodiak Sciences" from the U.S. Patent and Trademark Office for the exclusive use of Kodiak Sciences and its subsidiaries.

08:51 EDT Cardtronics appoints Michelle Moore, Rahul Gupta to board of directors - Cardtronics announced that former Bank of America executive Michelle Moore, and former CEO of RevSpring Rahul Gupta, have been appointed to its Board of Directors, effective immediately. Following 16 years of service on the Cardtronics Board of Directors, Jorge Diaz has decided to retire and will not seek re-election at the 2020 General Meeting. Mr. Diaz first joined the board in 2004. Ms. Moore will serve as a Class I director, and Mr. Gupta will serve as a Class II director.

08:49 EDT Uxin to sell its B2B business to 58.com for $105M - Uxin Limited announced that it entered into definitive agreements with 58.com, China's largest online classifieds and an existing investor in Uxin, to sell its B2B business. Pursuant to the definitive agreements, the Company will sell its entire B2B online used car auction business and transfer corresponding assets and liabilities to an affiliate of 58.com for a total cash consideration of $105 million, which may be slightly adjusted subject to the review of the transferred assets following the completion of the transaction. The Company agrees not to engage in or acquire any B2B used car auction business following the completion of the transaction without prior consent from 58.com. The transactions contemplated under the definitive agreements are subject to customary closing conditions, and are currently expected to close by the first half of 2020.

08:48 EDT ADT Inc. implements temporary, company-wide remote working mandate - The company said, "ADT instituted a number of policies and practices to support our team members who are facing very challenging times. These policies, which have already gone into effect, provide immediate relief due to missed work, lost wages and concerns about team member wellbeing. We have implemented a temporary, company-wide remote working mandate for positions that can begin remote work immediately. We have implemented flexibility in our attendance policy, including access to paid time off, that encourages employees to stay home if they feel ill or need to care for at-home children. ADT will pay employees 100% of regular compensation for up to two weeks if they're required to be quarantined due to the COVID-19 illness."

08:46 EDT ADT anticipates having 'sufficient liquidity' to weather current environment - The company said, "Despite the challenges to the global economy presented by COVID-19, ADT's recurring revenue business model and cash generation profile provides a solid financial foundation from which to continue to serve our customers and communities. Our business benefits from a strong recurring monthly revenue stream and a highly variable subscriber acquisition cost model. As such, we anticipate having sufficient liquidity to weather the current challenging macroeconomic environment and the slowdown brought on by COVID-19. Moreover, given the nature of our business model, in which slower gross adds lead to lower cash expenditures, we continue to expect to generate strong free cash flow before special items, even in the case of reduced near-term demand. Finally, we have no significant debt maturities until October 2021 and substantial room under any applicable financial covenants. As a result, we expect to continue to be in a strong position to serve customers and communities during this difficult time. "

08:44 EDT ADT Inc. CEO says company remains open for business - "As COVID-19 is testing our nation's resolve, it's also bringing out the best in many people and businesses, and this is especially true at ADT. Since we began preparing for the potential impact of COVID-19, I've seen a tremendous outpouring of compassion and commitment from our team members to support each other and help keep our customers safe," said Jim DeVries, President and CEO at ADT. "With the hard work of the ADT team and the support of state and local governments, we remain open for business and continue to secure our more than 6 million residential and commercial customers throughout the country."

08:42 EDT aTyr Pharma's Pangu awarded grant to fund bispecific antibody development - aTyr Pharma announced that the company's Hong Kong subsidiary, Pangu BioPharma Limited, together with the Hong Kong University of Science and Technology, has been awarded a grant of approximately $750,000 to build a high-throughput platform for the development of bi-specific antibodies. Initially the research focus will be on diseases, including cancer, in which Neuropilin-2 overexpression is strongly implicated. The two-year project is being funded by the Hong Kong Government's Innovation and Technology Commission under the Partnership Research Program. The PRP aims to support research and development projects undertaken by companies in collaboration with local universities and public research institutions. The grant will fund approximately 50% of the total estimated project cost, with aTyr contributing the remaining 50%.

08:41 EDT Comcast says 'impact of COVID-19 could have material adverse impact' on results - In a regulatory filing, Comcast stated: "The impact of coronavirus disease 2019 - COVID-19 - and measures to prevent its spread are affecting our businesses in a number of ways. For example, we have closed all of our theme parks; we have delayed theatrical distribution of films both domestically and internationally; and the creation and availability of our film and television programming in the United States and globally has been disrupted, including from the cancellation or postponement of sports events, including possibly the Olympics, and suspension of entertainment content production. As they affect Sky, these impacts materially exacerbate what was an already deteriorating economic environment and advertising market in the UK and Europe in 2019. Our Comcast Cable business, while our network performs well to meet the challenge of business and schooling from home, will not be unaffected either as economic stress impacts our residential and business services customer base. We expect that the ultimate significance of the impact of COVID-19 on our businesses will vary but will generally depend on the extent of governmental measures affecting day to day life and the length of time that such measures remain in place to respond to COVID-19. At this point, it is impossible to predict such extent and duration and the degree to which supply and demand for our products and services, including advertising, will be affected. This uncertainty makes it challenging for management to estimate the future performance of our businesses, particularly over the near to medium term. However, the impact of COVID-19 could have a material adverse impact on our results of operations over the near to medium term."

08:39 EDT Minerva to host key opinion leader meeting on roluperidone - Minerva Neurosciences announced that it will host a Key Opinion Leader call on roluperidone and the treatment of the negative symptoms of schizophrenia on Tuesday, March 31, 2020. Dr. Remy Luthringer, Executive Chairman and Chief Executive Officer of Minerva, will join William T. Carpenter, MD, University of Maryland, Ofer Agid, MD, University of Toronto, John Kane, MD, Hofstra University/ Northwell Health System, and Stephen Marder, MD, UCLA, to discuss the treatment of negative symptoms of schizophrenia. In the second quarter of 2020, Minerva expects to announce top line results from a Phase 3 study with roluperidone in patients diagnosed with schizophrenia with negative symptoms. Roluperidone is the only molecule in advanced clinical development that to date has shown a specific effect on negative symptoms in schizophrenia.

08:38 EDT Exagen appoints Debra Jeske Zack as CMO, Anja Kammesheidt as CSO - Exagen (XGN) announced the appointment of Debra Jeske Zack, M.D., Ph.D., as Chief Medical Officer, and Anja Kammesheidt, Ph.D., as Chief Scientific Officer. The addition of Drs. Zack and Kammesheidt to the Exagen team will strengthen the company as it continues to focus on clinical research and development initiatives to serve the needs of healthcare providers and their patients. . Prior to joining Exagen, Dr. Zack served as Vice President, Clinical Development at Xencor (XNCR). Prior to joining Exagen, Dr. Kammesheidt served as Chief Scientific Officer at Ambry Genetics and Pathway Genomics.

08:36 EDT Tabula Rasa HealthCare provides PACE access to COVID-19 testing kits - Tabula Rasa HealthCare is coordinating an effort to help Programs of All-Inclusive Care for the Elderly with access to COVID-19 testing kits. The testing kits are being made available through TRHC's PACE pharmacy, CareKinesis. In addition to providing PACE partners with the COVID-19 testing kits, TRHC's CareKinesis pharmacy is also offering the BioIntelliSense BioSticker which will allow PACE centers to remotely monitor patients for COVID-19 symptoms, including fever, cough, and shortness of breath. The BioSticker is the first FDA-cleared, single-use device enabling 30 days of continuous vital sign monitoring.

08:35 EDT ThermoGenesis, ImmuneCyte partner on developing COVID-19 tests - To effectively respond to the COVID-19 pandemic, ThermoGenesis and ImmuneCyte are working together mobilizing their expertise, global resources and relationships in the medical technology field to develop, register, import and seek U.S. FDA approval for advanced point-of-care tests that will allow rapid diagnosis of the COVID-19 virus, including asymptomatic cases. The tests would be able to be done both at point-of-care settings, or potentially at home, without further burdening the already stressed healthcare system. A quick do-it-yourself testing kit, as simple as a routine pregnancy test or diabetic glucose test, if approved, would allow millions of people currently quarantined at home to conduct a self-test. Management noted that the first of such a rapid point-of-care test could be available as early as April through ThermoGenesis and ImmuneCyte. "We expect to file for an expedited review process with the FDA for the assay," noted Dr. Xu.

08:35 EDT Dynavax, Clover Biopharmaceuticals announce research collaboration for COVID-19 - Dynavax and Clover Biopharmaceuticals announced that they have entered into a research collaboration to develop a vaccine candidate to prevent COVID-19. Clover is advancing evaluation of its protein-based coronavirus vaccine candidate (COVID-19 S-Trimer) in preclinical studies. Dynavax is providing technical expertise and the company's proprietary toll-like receptor 9 (TLR9) agonist adjuvant, CpG 1018, to support this initiative. In late-January 2020, upon knowing the genomic DNA sequence of the newly identified SARS-CoV-2 virus, which causes a disease named COVID-19, Clover scientists started designing the viral spike (S)-protein construct and completed its gene synthesis. Utilizing its patented Trimer-Tag technology, Clover has produced a COVID-19 S-Trimer subunit vaccine candidate that resembles the native trimeric viral spike via a rapid mammalian cell-culture based expression system. Having one of the largest in-house, commercial-scale cGMP biomanufacturing capabilities in China, Clover could potentially rapidly scale-up and produce large-quantities of a new coronavirus vaccine.

08:34 EDT Home Bancshares changes time, location of Annual Meeting of Shareholders - Home BancShares announced that due to the emerging public health impact of the COVID-19 pandemic and to support the health and well-being of our shareholders and other stakeholders, the Company has changed the time and location of its Annual Meeting of Shareholders to be held on April 16, 2020. The Annual Meeting will now be held at 9:00 a.m. on April 16, 2020 at the Company's corporate offices located at 719 Harkrider Street, Conway, Arkansas. Shareholders who vote their shares by proxy do not need to attend the Annual Meeting. The Company asks that any shareholders who do plan to attend the meeting please notify the Company at least 24 hours in advance of the meeting by contacting our Investor Relations Officer, Donna Townsell, at (501) 328-4625. In light of recent guidelines recommended by federal and state authorities and the Centers for Disease Control and Prevention restricting group gatherings, seating may be limited to comply with the applicable recommended guidelines. Additionally, attendees may be subject to health screening procedures upon entering the building consistent with practices advised by governmental authorities or as otherwise in place for visitors to the Company's corporate office. Whether or not shareholders plan to attend the meeting, the Company urges all shareholders of record as of the record date, February 24, 2020, to promptly submit their proxy by executing and returning the proxy card previously mailed to them or by voting by telephone or on the Internet by following the voting instructions printed on their proxy card. Your vote is important.

08:32 EDT ANI Pharmaceuticals submits PAS to FDA for Purified Cortrophin Gel - ANI Pharmaceuticals announced that it has submitted a prior approval supplement to the Endocrinology Division at the FDA for re-commercialization of Purified Cortrophin Gel. The current annual market for Cortrophin Gel is approximately $950M and has only one competitor. Cortrophin Gel was originally approved by the FDA in 1954 and last used in patients in the 1980s. Cortrophin Gel has over 54 indications on its previously approved label, including but not limited to acute exacerbations of multiple sclerosis, rheumatoid arthritis, systemic lupus erythematosus and ulcerative colitis.

08:31 EDT DarioHealth announces partnership with Vitality Group - DarioHealth announced that it has entered into a partnership with Vitality Group, a global health and wellness company. Under the partnership, Vitality will integrate Dario's digital therapeutics for chronic conditions into its current wellness solution platform and co-market the Dario solution to Vitality's existing client base. In conjunction with the partnership, Dario granted Vitality warrants that will become exercisable dependent on the success of the partnership over the next four years, beginning in 2020.

08:30 EDT Probe Metals completes acquisition of Monique property in Val-d'Or - Probe Metals announced the completion of previously announced acquisition of the Monique property from Monarch Gold Corporation. The details of the transaction and the property are described in the Company's press release dated March 2nd, 2020. Pursuant to the Agreement, Probe acquired a 100% interest in the Property by issuing 1,275,510 common shares to Monarch for a total value of $1.5 million based on a 30-day volume weighted average price of $1.176 per share on the TSX Venture Exchange as of March 2nd, 2020. The common shares issued have a hold period of four months and one day from closing. Probe will also assume any reclamation liabilities associated with the past-producing Monique open pit mine.

08:27 EDT Seelos Therapeutics announces interim data from Phase I studies of SLS-002 - Seelos Therapeutics announced additional interim data from its Phase I studies of Intranasal Racemic Ketamine . Seelos also announced that it completed its Type C meeting with the U.S. Food and Drug Administration as scheduled to discuss the protocol design for a study of SLS-002 for Acute Suicidal Ideation and Behavior in patients with Major Depressive Disorder. Interim data disclosed includes the hemodynamic side effect profile to address the known and expected side effects of ketamine, which are increases in blood pressure and heart rate. Some of the key highlights of the interim vital signs adverse events data for all 104 subjects from the Phase I studies include: All vital signs related AEs observed in the combined studies, SLS-002-101 and SLS-002-102, were mild and transient in nature. No serious adverse events related to vital signs were observed. In the open label study, SLS-002-101, only 5 out of 42 subjects experienced mild and transient AEs. In the blinded study, SLS-002-102, only 10 out of 62 subjects experienced mild and transient AEs; the distribution of these AEs across the 6 arms will be known upon unblinding the studies. Additional data from the Phase I studies is expected to be released early in the second quarter of 2020 once all dose cohorts are unblinded and evaluated.

08:23 EDT CPI Aerostructures deemed exempt from NYS 'work from home' mandate - CPI Aerostructures announced that it has been classified as an 'essential business' by New York State and is, therefore, exempt from the state's mandate that all non-essential New York businesses close until further notice. The New York State exemption follows the statement issued by the Under Secretary of Defense for Acquisition and Sustainment on March 20, 2020 declaring that defense contractors are 'critical infrastructure' to national security.

08:18 EDT SurveyMonkey launches resources to help customers during COVID-19 crisis - SurveyMonkey launched several new resources to help address the challenges that many are faced with during the COVID-19 global crisis. The new resources, including real-time data and survey tools, aim to help make every voice count during a time when human connection and experiences are more important than ever. Real-time data: Tracked through SurveyMonkey Audience, anyone can now have access to the latest data on Americans' thoughts and feelings about coronavirus, the economy and everything in between. Survey Questionnaire Templates: With many people working remotely, leaders can use survey questionnaire templates to help understand what their employees are thinking, feeling and prioritizing during the COVID-19 crisis. Similarly, school systems face unique logistical challenges as they attempt to implement distance learning programs for students with variable needs and access to resources. Written by the company's survey research experts, these new survey templates can help users easily collect, analyze and act on feedback: Coronavirus template for leaders and HR: Designed for executive leadership teams to keep a pulse on employees' wellbeing and ensure they have the support to work remotely. Work from home check-in: Designed to be sent regularly by managers to assess whether employees who are working remotely have the proper support. K-12 Distance Learning: Designed to help K-12 school administrators understand how to best serve students and parents in a distance learning environment. For a period of time, SurveyMonkey is also offering discounted plans for students and educators. An additional resource is available to help users understand and decide if they should send a survey, and a step-by-step guide on deploying a coronavirus employee survey.

08:16 EDT Credicorp donates S/ 100M to support Peruvian families - Credicorp announced that its subsidiaries, Banco de Credito del Peru and Mibanco, decided to donate S/ 100 million and S/ 10 million, respectively, initiating a donation fund to support Peruvian families that are under a situation of poverty or extreme poverty, whose income has beenaffected by the national emergency declared related toCOVID-19. Moreover, BCP launched a campaign, to motivate other companies and individuals, to join and increase the donation fund solidarizing with the most vulnerable families. Given the declaration of a national emergency by the Peruvian government through Supreme Decree No. 044-2020-PCM, which orders social isolation to prevent the transmission of COVID-19 in Peru, the most affected population will be those who live generating income on adaily basis. The Peruvian government is already supporting each of these families through a S/ 380 one-off payment, and Credicorp, through its subsidiaries BCP and Mibanco, is additionally committingto further support these families. Additionally, BCP proactively launched the campaign "Yo me sumo", motivating other companies and people in general to join this social initiative and donateresources to help the most needed population. As such, BCP is making available all its digital channels to facilitate clientdonations. Non-clients will be able to donate through interbank transfers, and through branches and agentesacross Peru. Porque cada sol suma, Yo me sumo", says the campaign. The distribution of the fund to the families will be made through the same mechanism the Ministry of Development and Social Inclusion has put in place to distribute the solidarity bonus to these families.

08:15 EDT Magnolia Oil & Gas provides update on current operations - Magnolia Oil & Gas provided an update to its operations and first quarter guidance in response to recent product price and market volatility. Magnolia's business model prioritizes free cash flow, financial stability, and prudent capital allocation, and is designed to withstand challenging environments such as the one we are currently experiencing. In line with the guidance provided in Magnolia's fourth quarter operating results, the company's ongoing plan is to spend approximately 60 percent of its adjusted EBITDAX on drilling and completing wells, providing consistent free cash flow generation, while maintaining low leverage and moderate production growth over time. Magnolia expects its capital outlays to be approximately half the levels of last year, and the company expects to generate free cash flow during 2020 which can be used to further improve the business as opportunities emerge. In response to the sharp decline in product prices, Magnolia plans to adjust its drilling and completion activity this year so that its capital spending is in line with its business model. As a result, the company plans to drop its one operated rig in the Karnes area at the end of the first quarter. The company is well positioned to make this adjustment given the significant flexibility within its capital program, as both of its operated drilling rigs are on short-term contracts and the company has no long-term service obligations. Moreover, Magnolia is not required to drill to maintain any of its credit metrics nor does it have any contractual drilling obligations, and nearly all the company's acreage is held by production. If the current environment persists, Magnolia expects to cease its remaining operated activity across its asset base. Magnolia's first quarter production is expected to be at least 66 Mboe/d, above its earlier guidance, with oil production consisting of at least 53 percent of total volumes. While the company's capital spending will be heavier during the first quarter, Magnolia expects to generate free cash during the period. Spending is expected to fall sharply during the remainder of this year to accommodate the company's business model. Magnolia's non-operated program remained very active during the first quarter and in line with expectations. While some non-op well activity could be curtailed in the existing environment, Magnolia expects that its participation in non-op activity will continue to the extent these programs are supported by strong economics. The company is currently working with many of its vendors and suppliers to reduce the cost of their services in order to improve its margins.

08:14 EDT Synalloy gets notice from Privet, UPG with intention to replace board members - Synalloy announced that it received notice that Privet Fund Management and UPG Enterprises intend to nominate a slate of five director designees for election to the company's board of directors to replace a majority of the board at the 2020 annual meeting of shareholders. The board will review Privet's and UPG's nomination notice, including the qualifications of Privet's and UPG's director designees, and will make recommendations concerning the election of directors in the company's definitive proxy statement that will be filed with the SEC in connection with the annual meeting. The date of the annual meeting has not yet been announced and shareholders are not required to take any action at this time.

08:13 EDT Aravive announces initiation of investgator-sponsored Phase 1/2 study of AVB-500 - Aravive announced that the first patient has been dosed in an investigator-sponsored Phase 1/2 clinical trial of the company's GAS6/AXL inhibitor AVB-500 in combination with PD-L1 inhibitor avelumab in patients with advanced urothelial carcinoma. The study is being led by Abhishek Tripathi, M.D., Assistant Professor of Medicine, Section of hematology/oncology at the University of Oklahoma Stephenson Cancer Center. The COAXIN study is a multi-center, single arm, Phase 1/2 trial evaluating safety and preliminary antitumor efficacy of avelumab in combination with AVB-500 in patients with advanced UC. The trial starts with a Phase 1 cohort to establish the maximum tolerated dose of AVB-500 in combination with avelumab and to allow for assessment of potential dose-limiting toxicities. The primary endpoint of the study is objective response rate. Secondary outcome measures include progression free survival, clinical benefit rate, duration of response and overall survival. The trial is listed on clinicaltrials.gov NCT04004442. Patient enrollment and continuation on study may be impacted by COVID-19.

08:13 EDT Capstone Turbine enacts business continuity plan, furloughing 70% of workforce - Capstone Turbine announced that in response to the global COVID-19 pandemic it has enacted a new Business Continuity Plan designed to keep employees safe as well as support the company's stated goal of reaching Adjusted EBITDA positive in the upcoming June quarter. A critical part of the Business Continuity Plan is the Capstone Leadership Team volunteering to take a 25% temporary salary cut as well as the fiscal 2020 Executive Bonus in equity in lieu of cash if earned. In addition, approximately 25 other top company managers volunteered to take a similar 15% reduction in salary. "With over 1000 confirmed cases in California and a "Shelter-in-Place" order for all of California, we enacted an emergency Business Continuity Plan designed to keep employees safe, continue to support our critical Aftermarket Factory Protection Plan, or FPP, long-term service contracts and spare parts deliveries to our Essential Critical Infrastructure Customers, such as Energy, Health Care, Wastewater Treatment, etc. as well as to sustain our key long-term business initiatives," said Darren Jamison, President and CEO of Capstone. "In these unprecedented and uncertain times, the health and safety of our Capstone and distributor employees, their families, and our communities are of the highest importance as well as doing everything possible to still deliver on our stated goal of positive EBITDA by reducing operating expenses and leveraging our high margin recurring revenue streams," added Mr. Jamison. As part of the comprehensive Business Continuity Plan, Capstone is taking the following steps: Beginning March 30th, Capstone is furloughing approximately 70% of its direct workforce, leaving behind only staff deemed essential for day-to-day administrative operations for a minimum period of 45 days. This will ensure those who remain can more easily practice safe and proper social distancing. During this period, Capstone will have a limited production capability of new microturbine products, but has recently pre-built approximately 5MW of microturbine finished goods for shipment during this period of suspended production. Capstone will maintain a crew of essential operations employees to manufacture service engines, remanufacture spare parts and provide service spares in support of FPPs and global distributor spare parts orders and is pre-building and shipping immediately to sustain our critical customer sites during this time of uncertainty.

08:12 EDT ReWalk Robotics says managing expenses to maintain runway into early 2021

08:11 EDT ReWalk Robotics expects coronavirus to impact sales in late Q1, coming quarters - ReWalk Robotics issued the following letter to shareholders:"The emerging coronavirus outbreak represents a challenge to our community and all of our stakeholders. This letter is an update on this situation as it pertains to ReWalk Robotics and our global operations. We fully support the efforts of all clinics and customers to manage this pandemic. Our clinics are focused on managing the emergency and therefore have limited in-person contact and elective activities. We encourage our home, community and clinic-based users of our products to follow the relevant local and national public health protocols and recommendations as provided. We have taken extensive steps to safeguard our employees with the majority working remotely, curtailing business travel, while maintaining supply chain activity as needed and seek to cover all service needs remotely or by shipping temporary replacement systems until we can repair their existing system. The health and well-being of our employees, customers and health care workers we serve remains a top priority. We will follow the guidance of public health officials as the situation develops and will reschedule training programs that had been planned for 2020 as needed. We expect this situation to delay direct sales activities, training and service contacts which will impact our sales in late Q1 and in coming quarters, lasting until the limits on activities for training and trial use are lifted. The insurers and other purchasers of our products are processing sales that are in our pipeline; however, training and delivery will be limited until all conditions are deemed safe for our employees, rehabilitation personnel and the users of our products. Our pipeline with insurers in Germany and with the U.S. Department of Veterans Affairs remains active now that the clinical study recruitment is complete and we will seek to supply those systems and further grow it as conditions allow in 2020 and 2021. Our current supply chain has adequate inventory in the form of finished goods and raw materials to meet our expected needs for 2020. We have strengthened our balance sheet during the last 12 months to ensure sufficient cash reserves for 2020 and are managing expenses carefully to maintain our runway into early 2021. We are confident that we are stable, and that we have taken all precautions to keep our employees and customers safe. We are committed to our long-term mission of providing powered solutions for persons with lower limb disability and the clinicians who treat them."

08:10 EDT Inovio, Ology Bioservices partner to manufacture COVID-19 DNA vaccine - Ology Bioservices and Inovio Pharmaceuticals announced that the Department of Defense has awarded Ology Bioservices with a contract valued at $11.9M to work with Inovio on DNA technology transfer to rapidly manufacture DNA vaccines. This work is supported by the Office of the Assistant Secretary of Defense for Health Affairs with funding from the Defense Health Agency. Under this program, Ology Bioservices will work with Inovio Pharmaceuticals to manufacture Inovio's DNA vaccine for prevention of infection with the COVID-19 virus. The aim of the program is to rapidly and efficiently deliver the vaccine to the Department of Defense for upcoming clinical trials.

08:09 EDT Brunswick announces publication of first sustainability report - Brunswick Corporation announced the publication of its first Company-wide Sustainability Report. Themed "Thinking Beyond the Horizon", the report is part of the Company's broad commitment to continually advance the Environmental, Social and Governance performance of its business and leverage its considerable resources and scale to address improvement opportunities important for the future of outdoor recreation and its stakeholders. Leveraging the decade-long success of the Sustainability program established at its largest Division - Mercury Marine, Brunswick used the award-winning strategy of its engine business to drive the multi-year effort across the balance of its marine enterprise. Focused on the pillars of energy, environment, products and people, the report highlights the Company's ESG accomplishments and its long-term goals and objectives.

08:08 EDT Occidental Petroleum elects Stephen Chazen to Chairman of Board - Occidental Petroleum (OXY) announced that Stephen Chazen, the Chairman and CEO of Magnolia Oil and Gas (MGY), effective March 18, has been elected to its Board of Directors as Chairman of the Board. Chazen has more than 30 years of experience in the oil and gas industry. Prior to founding the NYSE listed Magnolia Oil and Gas Corporation in 2018, Chazen served as CEO of Occidental from 2011 to his retirement in 2016 and as a director from 2010 to 2017.

08:07 EDT Luby's temporarily suspended all operations at additional locations - Luby's announced that, as a result of the rapidly evolving COVID-19 pandemic, the Company is taking additional proactive steps to mitigate negative financial and operational impacts. Accordingly, it has temporarily suspended all operations at 29 additional Luby's Cafeterias and 5 additional Fuddruckers locations as well as our only Cheeseburger in Paradise location. We currently continue to operate 34 Luby's Cafeterias and 3 Fuddruckers restaurants to serve our guests during these times. It is our honor to serve our guests and our communities at our open locations, and we eagerly await the opportunity to reopen our temporarily suspended locations as soon as conditions improve. Also, as the result of the COVID-19 pandemic, the Company will place more than half of its corporate office general and administrative staff on furlough and the Company's remaining general and administrative staff and all senior management and other salaried employees will have their salaries temporarily reduced by 50%.

08:06 EDT Inovio and Ology awarded $11.9M contract by DOD - Ology Bioservices and Inovio Pharmaceuticals announced that the Department of Defense, or DOD, has awarded Ology Bioservices with a contract valued at $11.9M to work with Inovio on DNA technology transfer to rapidly manufacture DNA vaccines. This work is supported by the Office of the Assistant Secretary of Defense for Health Affairs with funding from the Defense Health Agency. Under this program, Ology Bioservices will work with Inovio Pharmaceuticals to manufacture Inovio's DNA vaccine for prevention of infection with the COVID-19 virus. The aim of the program is to rapidly and efficiently deliver the vaccine to the Department of Defense for upcoming clinical trials."

08:04 EDT TEN, Ltd. board authorizes $50M stock buyback program - The Company will pay a dividend of $0.05 per common share in June 2020 and has received authorization from the Company's Board of Directors to commence an up to $50 million common and preferred stock buyback.

08:03 EDT GM CEO says 'aggressively pursuing austerity measures' to preserve cash

08:02 EDT General Motors intends to drawdown approx. $16B from revolving credit facilities - General Motors announced that it intends to drawdown approximately $16B from its revolving credit facilities. This is a proactive measure to increase GM's cash position and preserve financial flexibility in light of current uncertainty in global markets resulting from the COVID-19 pandemic. The funds will supplement the company's cash position of approximately $15B-$16B expected at the end of March. "We are aggressively pursuing austerity measures to preserve cash and are taking necessary steps in this changing and uncertain environment to manage our liquidity, ensure the ongoing viability of our operations and protect our customers and stakeholders," said Mary Barra, GM chairman and CEO. "Over the past several years, we have made necessary, strategic decisions and structural changes that have transformed the company and strengthened the business, better positioning us for downturns." In addition, GM Financial had $24B of liquidity at the end of 2019 and expects to end the first quarter with similar levels of liquidity. Its liquidity level is targeted to support at least six months of cash needs, including new originations, without access to capital markets. GMF is managing below its target leverage ratios. "GM Financial has prepared for times like this by maintaining a strong financial position and ready access to cash. We are confident that we will be able to navigate the challenges created by this environment without capital from GM," said Dan Berce, GM Financial president and CEO. GM is also suspending its 2020 guidance due to uncertainty around the business impact of the COVID-19 pandemic.

08:01 EDT General Motors intends to drawdown approx. $16B from revolving credit facilities

07:43 EDT Black Diamond says continued to advance program in glioblastoma - The company "continued to advance its program in glioblastoma toward nominating a development candidate that targets a range of driver mutations in GBM and progress the Company's other earlier stage programs derived from Black Diamond's Mutation-Allostery-Pharmacology platform. Black Diamond's MAP platform is built on three central pillars - discover, reveal, and target. The Company uses population-level cancer genetic data obtained from all tumor types to identify potential families of mutations that occur within individual oncogenes and rank the mutations for potential oncogenicity. Black Diamond then uses its MAP platform to understand the mechanism for oncogenic activation and the Company's team of experienced medicinal chemists then develops mutation spectrum-selective drugs for the identified targets."

07:39 EDT Enzo Clinical Labs launches drive-through COVID-19 test facility on Long Island - Enzo Biochem announced its wholly owned subsidiary, Enzo Clinical Labs, Inc., has expanded its screening services for COVID-19. Following the company's March 6 announcement regarding the initiation of accepting specimens for novel Coronavirus (COVID-19) testing, Enzo is now directly collecting specimens at a drive-through facility by appointment in Enzo's laboratory complex in Farmingdale, New York. This facility has been set up with support from local and state officials. As one of the first independent drive-through testing facilities on Long Island, NY, it is easily accessible for Nassau and Suffolk County residents and is now in operation. The goal of this testing site is to help the local community improve virus surveillance and reduce pressure on the regional hospital systems.

07:38 EDT Ford partners with 3M and General Electric on producing respirators, ventilators - Ford (F), joining forces with firms including 3M (MMM) and GE Healthcare (GE), is lending its manufacturing and engineering expertise to quickly expand production of urgently needed medical equipment and supplies for healthcare workers, first responders and patients fighting coronavirus. In addition, Ford plans to assemble more than 100,000 face shields per week and leverage its in-house 3D printing capability to produce disposable respirators for healthcare workers. Ford team members are working with 3M to increase the manufacturing capacity of their powered air-purifying respirator, or PAPR, designs and working jointly to develop a new design leveraging parts from both companies to meet the surge demand for first responders and health care workers. This new respirator could be produced in a Ford facility by UAW workers. To go as fast as possible, the Ford and 3M teams have been locating off-the-shelf parts like fans from the Ford F-150's cooled seats for airflow, 3M HEPA air filters to filter airborne contaminants such as droplets that carry virus particles and portable tool battery packs to power these respirators for up to eight hours. Ford is looking at how it might produce these new-generation PAPRs in one of its Michigan manufacturing facilities, helping 3M boost production potentially tenfold. In addition, Ford and GE Healthcare are working together to expand production of a simplified version of GE Healthcare's existing ventilator design to support patients with respiratory failure or difficulty breathing caused by COVID-19. These ventilators could be produced at a Ford manufacturing site in addition to a GE location. Work on this initiative ties to a request for help from U.S. government officials. Meanwhile, Ford's U.S. design team also is quickly creating and starting to test transparent full-face shields for medical workers and first responders. The face shields fully block the face and eyes from accidental contact with liquids and when paired with N95 respirators can be a more effective way to limit potential exposure to coronavirus than N95 respirators alone. The first 1,000 face shields will be tested this week at Detroit Mercy, Henry Ford Health Systems and Detroit Medical Center Sinai-Grace Hospitals. Roughly 75,000 of these shields are expected to be finished this week and more than 100,000 face shields per week will be produced at Ford subsidiary Troy Design and Manufacturing's facilities in Plymouth, Michigan. Ford is leveraging its Advanced Manufacturing Center in Redford, Mich., and in-house 3D printing capabilities to manufacture disposable respirators, which are needed to help filter the air healthcare workers and first responders breathe. Once approved by the proper health agency, Ford will initially start at a pace equal to 1,000 per month but will quickly grow production as fast as possible. Ford is evaluating a separate effort not involving GE Healthcare with the U.K. government to produce additional ventilators. In China, Ford of China joint venture partner Jiangling Motors also has donated 10 specially equipped Transit ambulance vans to hospitals in Wuhan, where the coronavirus outbreak began. Ford is also reacquiring 165,000 N95 respirators from China that were originally sent by Ford to China earlier this year to help combat coronavirus. Ford has also kicked off a working team to help hospitals locate and secure urgently needed surgical and N95 respirators. Ford has so far committed sending Henry Ford Health Systems 40,000 surgical masks while it locates additional supplies.

07:35 EDT Muscle Maker ramps up delivery, establishes royalty deferment program - The company said, "We want to provide a brief update on the current operating environment in response to the ongoing COVID-19 pandemic. While this is proving to be a difficult operating environment across all industry sectors, we view the role of the food industry as crucial, and we remain committed to ramping up operations to continue to serve Americans during this difficult time. Not only are we continuing to serve our guests, from our corporate restaurants and existing franchise model, but also to maintaining an eye on the future, so that we can be prepared for any shifts in the marketplace. We believe our recent announcements regarding Fort Bragg and the 10 location commitment for the delivery-only kitchens provides a clear indication of the non-traditional development direction that we are executing, in spite of the current climate and helps to best position the company for the future. We are taking considerable strides to protect both our employees and our guests as it relates to safety protocols. A standard operating procedures guide covering guest safety measures, employee wellness, and restaurant sanitation has been sent to the entire Muscle Maker Grill system. Detailed instructions were included to ensure that we continue to uphold our brand standards. Given the operational differences within our model, these protocols vary slightly between military and non-military locations, but we remain open for take-out and delivery in most restaurants. While some of our restaurants have closed temporarily, most remain open but have reduced their hours of operation to comply with state and city recommendations, and to give our employees ample time to return home to their families. Muscle Maker Grill is doing its part to meet the demand of delivering healthier food directly to our guests in the face of social distancing. Our staff and prep facilities are prepared and in addition we have launched 3rd party ordering in all applicable corporate restaurants to provide safe and convenient ordering for all guests. Guests also have the option to place orders for delivery through the MMG Rewards app or online at https://musclemakergrill.com/order-now/. The brand is running targeted ads around all restaurants, corporate and franchised, on social media to drive healthy meal plan sales. Delivery specific offers are available to the franchise community and are being distributed by the MMG Rewards email program. In addition, we have introduced our free nutrient dense immunity boosters to be included with smoothie and shake purchases for those looking to give their immune systems a healthy boost. In an effort to share the burden and show that we're all in this together, we have set up a royalty deferment program for our franchise community. Franchisees are eligible to receive a 50% deferment on royalties and a reduction in their marketing/advertising contribution. The program is available for 30 days but will be reevaluated based on market conditions at its conclusion."

07:32 EDT Spirit AeroSystems suspends Boeing production work - Spirit said, "Following Boeing's (BA) announcement to temporarily suspend production at its Washington state facilities, Spirit AeroSystems (SPR) will also suspend Boeing work performed at our facilities in Wichita, Kansas, and in Tulsa and McAlester, Oklahoma. This action will begin Wednesday, March 25, and last 14 calendar days, until April 8. Spirit will continue to support 787 work for Boeing's Charleston, South Carolina, facility as needed. We will continue to pay employees who are sent home during this two-week period due to the suspension of Boeing work. Spirit will use the time to further deep clean and sanitize work spaces and facilities as we continue to take precautions to protect the health and safety of our team. Our focus is on a safe and orderly restart of operations. When production does resume on our Boeing programs, we will align our costs and workforce to the new level of production set by Boeing. This could potentially include additional workforce actions. Operations in support of our defense customers, Airbus (EADSY), aftermarket and MRO, third party fabrication work, other non-Boeing work, and other growth programs will continue. Those employees should expect to work their regular schedules. Spirit continues to monitor ongoing events as result of the COVID-19 pandemic and will take precautions and make adjustments to its operations as needed for the safety of our team."

07:28 EDT Qiwi says not able to accurately estimate the potential impact of COVID-19 - The company said, "The outbreak of the COVID-19 strain of coronavirus and associated responses from various countries around the world is likely to negatively affect consumer demand across the globe and across industries, and there is the potential for COVID-19 and the responses to it to cause a global recession. At this moment we are not able to accurately estimate the potential impact of the COVID-19 on our business, including the negative effect on the betting industry in general and our revenue generated from products and services we provide to our betting merchants caused by postponement and cancellation of the major sports events. In addition, it is currently unclear how much consumer demand will be negatively affected by the outbreak of COVID-19 and what effect the outbreak of COVID-19 will have on the macroeconomic environment, as a whole. The full impact remains uncertain and will depend on the length and severity of the effect of the coronavirus on economic activity in our markets. The full scope of the negative impact that the abrupt decline in oil prices and resulting devaluation of the ruble may have on the Russian economy also remains unclear but has the potential to be very significant. Our outlook reflects our current views and expectations only and is based on the trends we see as of the day of this report. If such trends were to deteriorate further the impact on our business and operations could be more severe than currently expected. We continue to monitor the situation closely. Further, the Compensation Committee of the Group has recently approved certain changes to our organizational structure. Following these changes, certain costs will no longer be allocated to the Payment Services Segment, but rather to the Corporate category or allocated between the segments. We are currently reviewing our allocation policies and aim to adjust the reporting to better reflect the new structure starting from the first quarter 2020. Consequently, we refrain from providing standalone PS Net Profit Guidance and present only the Group Net Profit guidance."

07:16 EDT Surna downsizes operations, including workforce reductions - The company said, "A number of recent events have had an adverse impact on our operations and financial condition, including constraints on capital availability for our customers and prospects who have commenced, or are contemplating, new and expanded cannabis cultivation facilities and the recent outbreak of COVID-19, a novel strain of coronavirus, which has spread across the globe including the U.S. Most recently, the response to this coronavirus by federal, state and local governments in the U.S. has resulted in significant market and business disruptions across many industries and affecting businesses of all sizes. This pandemic has also further tightened capital access for most businesses. As a result of these events, we assessed our near-term operations, working capital, finances and capital formation opportunities, and implemented, in late March 2020, a downsizing of our operations, including workforce reductions, reductions of salaried employee compensation and a reduction of hours worked to preserve cash resources, cut costs and focus our operations on customer-centric sales and project management activities. The extent to which COVID-19 will impact our business and financial results will depend on future developments, which are uncertain and cannot be predicted at this time. The duration and likelihood of success of this downsizing effort, workforce reduction and cost-cutting measures are uncertain. If these actions do not meet our expectations, or additional capital is not available, we may not be able to continue our operations. In addition, any potential government mandate to limit non-essential work would have a material adverse effect on management's revised plans. If our customers or prospects are unable to continue operations or obtain project financing and we are unable to increase revenues, or otherwise generate cash flows from operations, we will not be able to successfully execute on the various strategies and initiatives to grow our business."

07:14 EDT Phillips 66 announces actions in response to business environment - Phillips 66 announced actions in response to the challenging business environment. "Phillips 66 is well positioned to manage through the challenging environment with our high-quality, diversified asset base and strong balance sheet," said Greg Garland, chairman and CEO of Phillips 66. "Our top priorities remain the well-being of our employees, our communities, and safe and reliable operations. We are taking action to maintain our financial strength to ensure security of our dividend, execute capital growth projects that are near completion, and maintain our strong investment grade credit rating. We remain focused on disciplined capital allocation and creating long-term value for our shareholders." The company is reducing 2020 consolidated capital spending by $700M to $3.1B. Capital spending net of cash capital contributions from joint venture partners is now expected to be $3B. This reduction in adjusted capital from the $3.3B budget reflects a $700M reduction in our consolidated capital spending, partially offset by a $400M reduction in cash capital contributions anticipated from DCP Midstream. In midstream, the Red Oak Pipeline and Sweeny Frac 4 projects, as well as Phillips 66 Partners' Liberty Pipeline, will all be deferred. Phillips 66 Partners has also postponed its final investment decision on ACE Pipeline. Phillips 66 does not expect DCP Midstream to exercise its option to participate in Sweeny Fracs 2 and 3 in 2020. In refining, the company is deferring and cancelling certain discretionary projects. The company is reducing operating and administrative costs by $500M in 2020. Phillips 66 temporarily suspended share repurchases effective March 18. Share repurchases during Q1 were approximately $440M. Phillips 66 will evaluate timing to resume share repurchases. Additionally, the company secured a new $1B, 364-day term loan facility. This facility provides additional liquidity and financial flexibility in addition to the existing $5B revolving credit facility. Phillips 66 Partners has a $750M revolving credit facility.

07:08 EDT NYFDS reapproves acquisition of Genworth insurance company by China Oceanwide - Genworth Financial and China Oceanwide Holdings Group announced that the New York State Department of Financial Services or NYDFS, has reapproved the proposed acquisition of control by Oceanwide of Genworth's New York-domiciled insurance company, Genworth Life Insurance Company of New York, or GLICNY. NYDFS' original approval expired in March 2019. In connection with the NYDFS' reapproval, Genworth has agreed, among other things, to contribute $100M to GLICNY at the closing of the Oceanwide transaction. Genworth and Oceanwide have communicated the terms of the agreement with the NYDFS to Genworth's other domiciliary insurance regulators, and believe that these terms are acceptable to them as well. Given the ongoing challenges due to the coronavirus pandemic, including the remote work policies that have been put into effect for the parties and regulators involved, the submission of additional information and the review processes have taken and may continue to take more time than would ordinarily be expected. Once these items are resolved, Oceanwide will be in a position to request clearance in China for the currency conversion and transfer of funds in order to complete the transaction. As a result, Genworth and Oceanwide are discussing a short extension of the merger agreement beyond the current deadline of March 31.

07:08 EDT Ampio suspends patient enrollment in Phase 3 clinical trial of Ampion - Ampio announced that it has suspended patient enrollment in its Phase 3 clinical trial of Ampion for the treatment of severe osteoarthritis of the knee. The trial focuses on individuals with the most severely diseased OAK, which represents an underserved patient population typically excluded from clinical studies because of the intractable nature of their condition. The average and maximum age of a patient in the AP-013 clinical trial is 65 and 87 years old, respectively. The Centers for Disease Control and Prevention have indicated that older adults, 65 years and older, are at higher risk for severe illness during the current COVID-19 pandemic. The Safety Monitoring Committee for the AP-013 clinical trial has unanimously recommended, following an interim analysis and due to extenuating circumstances relating to the COVID-19 virus, to minimize risk to study participants that, "The study cease enrolling patients because the number of injected patients, 1,019, is sufficiently close to the number of patients called for by the sample size re-estimation algorithm, 1,034."The FDA has recognized that challenges may arise, for example, from quarantines, site closures, travel limitations, and/or other considerations due to the pandemic. The Contract Research Organization running the AP-013 clinical trial for the company has notified the company that due to the COVID-19 virus, all travel has been suspended for clinical study monitors, which severely limits our ability to monitor the conduct of the AP-013 clinical trial. Recognizing these challenges, the Company is exploring options to enable it to complete the trial but notes that it is possible that the COVID-19 pandemic may prevent completion of the AP-013 trial at this time or at all. Concurrently, the company is focusing on investigating the potential use of nebulized Ampion for the treatment of a serious complication of COVID-19, the rapid onset of respiratory failure, termed Acute Respiratory Distress Syndrome. Based on Ampion's immunomodulatory and anti-inflammatory action, we believe that it may help individuals with widespread inflammation in the lungs and may reduce this serious complication of COVID-19.

07:06 EDT Applied DNA files provisional patent for high-sensitivity COVID-19 assay - Applied DNA Sciences announced the filing of a provisional patent application with the United States Patent and Trademark Office, or USPTO, for its diagnostic assay under development for SARS-CoV-2, the virus that causes the disease COVID-19. The application follows the company's announcement on March 19, 2020 that it had completed the design of its COVID-19 detection assay.

07:05 EDT Medipharm Labs to export shipment of GMP cannabis extract to Australia - MediPharm Labs announced its subsidiary MediPharm Labs Australia Pty has received the necessary permits to import a large shipment of GMP cannabis oil from its other subsidiary MediPharm Labs upon receipt of export permits. This shipment will further support the Company's international supply chain and accelerates MediPharm Labs Australia's ability to supply pharmaceutical-quality cannabis extracts and finished products to begin addressing Australian market demand for medicinal patients as well as for research and development.

07:03 EDT Axalta Coating says 'no significant disruptions' to supply chain - Axalta is actively monitoring and managing supply chain challenges, including logistics, but thus far, there have been no significant disruptions. Axalta's supply chain team is coordinating with the company's suppliers to identify and mitigate potential areas of risk and manage inventories.

07:02 EDT Invesco Mortgage gives update on financing agreements, delays dividend payment - Invesco Mortgage announced that in recent weeks, due to the turmoil in the financial markets resulting from the global pandemic of the COVID-19 virus, the company and its subsidiaries have received an unusually high number of margin calls from financing counterparties. Through Friday, March 20, the company had timely met all margin calls received. However, on March 23, the company notified its financing counterparties that it was not in a position to fund the margin calls that it received on March 23 and that the company did not expect to be in a position to fund the anticipated volume of future margin calls under its financing arrangements in the near term as a result of market disruptions created by the COVID-19 pandemic. The company further announced that it is engaged in discussions with its financing counterparties with regard to entering into forbearance agreements pursuant to which each counterparty would agree to forbear from exercising its rights and remedies with respect to an event of default under the applicable financing arrangement for an agreed-upon period. The company cannot predict whether its financing counterparties will enter into a forbearance agreement, the timing of any such agreement, or the terms thereof. In addition, in order to preserve liquidity until it can more accurately assess the impact that current market conditions in fixed income markets will have on the company's balance sheet and overall liquidity, the company announced that it will delay the payment of its previously announced quarterly cash dividends on the company's common stock, 7.75% Series A Cumulative Redeemable Preferred Stock, 7.75% Fixed-to-Floating Series B Cumulative Redeemable Preferred Stock and 7.50% Fixed-to-Floating Series C Cumulative Redeemable Preferred Stock. The quarterly cash dividend of 50c per share on the company's common stock had been declared on March 17 and was to be paid on April 28 to all stockholders of record as of March 30. The company will continue to evaluate its liquidity situation and plans to provide updates regarding new payment dates and, if necessary, new record dates, for the dividends once such dates have been determined.

06:58 EDT Geo Group subsidiary awarded contract with U.S. inmigration services - The GEO Group announced that its wholly-owned subsidiary, BI Incorporated, has signed a contract with U.S. Immigration and Customs Enforcement for the continued provision of case management and supervision services under the federal government's Intensive Supervision and Appearance Program. The contract will have a term of five years, effective April 1 and is expected to serve 90,000 to 100,000 participants daily, consistent with the average number of daily participants during the past year.

06:53 EDT Chevron says COVID-19 impact on financial results 'could be material' - The company stated, "Recent decreases in commodity prices, as a result of COVID-19 impacts on reduced demand and geopolitical pressures increasing supply, are expected to negatively impact the company's future financial and operating results. Due to the rapidly changing environment, there continues to be uncertainty and unpredictability around the impact on our results, which could be material. We expect to provide further updates in the company's first quarter 2020 earnings press release, earnings call, and Form 10-Q."

06:52 EDT Alamos Gold announces fourteen day suspension of operations and other measures - Alamos Gold provided an update on the measures it has instituted to prevent the spread of COVID-19 including a 14 day suspension of operations at Island Gold. To date, Alamos has not had any confirmed cases of COVID-19 among any of its employees or contractors and has not experienced any impact to its operations or its supply chain. Over the past two weeks, the Company has instituted a number of measures to help prevent the spread of COVID-19 and protect the health and well-being of its employees and contractors, their families, and the local communities. This includes temporarily suspending operations at its Island Gold mine given the unique set-up of the operation with both a large local community and fly-in, fly-out workforce. The Company continues to closely monitor the situation and will institute additional measures as appropriate. To date, operations at Young-Davidson and Mulatos have not been impacted. The Company is on track to achieve consolidated production guidance for the first quarter of 2020 of 105,000 to 110,000 ounces of gold.

06:50 EDT Vista Gold announces positive results from feasibility study of Todd project - Vista Gold announced results of an independent benchmarking study of the 2019 updated preliminary feasibility study for the Mt Todd Gold Project in the Northern Territory, Australia. In the Q2 of FY19 Vista engaged GR Engineering Services, or GRES, of Perth, Australia to complete an independent review of capital and operating costs, and construction, commissioning and ramp-up schedules as presented in the 2019 PFS. The objective of the Study was to assess the capital and operating costs, and schedules presented in the 2019 PFS compared to actual capital and operating costs being experienced by current, similar size operations. The findings were positive and provide greater assurance that the Company's inputs and assumptions are reasonable and that the schedules are practical.

06:47 EDT Chevron cuts FY20 CapEx plan by $4B, suspends share repurchase program - Chevron announced several steps it is taking in response to market conditions. "With an industry leading balance sheet and a flexible capital program, we believe Chevron is resilient and positioned to withstand this challenging environment," said Chevron Chairman and CEO Michael Wirth. "Given the decline in commodity prices, we are taking actions expected to preserve cash, support our balance sheet strength, lower short-term production, and preserve long-term value." The company is reducing its guidance for 2020 organic capital and exploratory spending by 20% to $16 billion. Reductions are expected to occur across the portfolio and are estimated as follows: $2 billion in upstream unconventionals, primarily in the Permian Basin; $700 million in upstream projects and exploration; $500 million in upstream base business spread broadly across our U.S. and international assets; $800 million in downstream & chemicals and other; Cash capital and exploratory expenditures are expected to decrease by $3.3 billion to $10.5 billion in 2020. Total capital and exploratory spending in the second half of 2020 is expected to be about $7 billion, an annual run rate 30% lower than the approved budget announced in December 2019. Excluding 2020 asset sales and price related contractual effects, the company expects 2020 production to be roughly flat relative to 2019. Note that Chevron's net production increases about 20,000 barrels of oil equivalent per day for each $10 movement lower in Brent oil prices due to contractual effects. Permian production by the end of the year is expected to be about 125,000 barrels of oil equivalent per day, or 20%, below prior guidance. "The flexibility of our capital program allows us to respond to these unexpected market conditions by deferring short-cycle investments and pacing projects not yet under construction," said Jay Johnson, Executive Vice President of Upstream. "At the same time, we are focused on completing projects already under construction that will start-up in future years while preserving our capability to increase short-cycle activity in the Permian and other areas when prices recover." In addition to reducing capital expenditures, the company is taking other actions to support its industry leading balance sheet including: The $5 billion annual share repurchase program has been suspended after repurchasing $1.75 billion of shares during the first quarter. The company completed the sale of its interest in the Malampaya field in the Philippines with proceeds over $500 million received in the first quarter. In April, the company expects to close the sale of its upstream interests in Azerbaijan and its interest in a related pipeline. The company continues to execute its plans to reduce run-rate operating costs by more than $1 billion by year-end 2020. "Chevron's financial priorities remain unchanged," said Chevron CFO Pierre Breber. "Our focus is on protecting the dividend, prioritizing capital that drives long-term value, and supporting the balance sheet."

06:40 EDT Ampio prepares expanded access FDA protocol to study Ampion in ARDS - Ampio announced that it is preparing an expanded access FDA protocol to study potential benefit of nebulized treatment with Ampion in SARS-Cov-2 induced Acute Respiratory Distress Syndrome, or ARDS, an immediately life-threatening condition. Ampio's Scientific Advisory Board, or SAB, members determined after a review of the published articles on the properties of Ampion, that nebulized Ampion may be suitable to treat another inflammatory indication. Specifically, ARDS, one of the most dreaded complications of COVID-19 is associated with widespread inflammation in the lungs. The underlying mechanism of ARDS involves diffuse injury to cells which form the barrier of the microscopic air sacs of the lung, surfactant dysfunction, and activation of the immune system. The fluid accumulation in the lungs associated with ARDS is partially explained by vascular leakage due to inflammation. Ampion is an aqueous solution that may be delivered through nebulization and may be suitable for suppressing inflammation in the lungs. Ampion is a human blood derived composition, currently approved for clinical use by the FDA, as an anti-inflammatory, immunomodulating drug. The novel mode of action of Ampion involves multiple biochemical pathways associated with resolving inflammation1 which make it a potential therapy for ARDS. An important aspect of ARDS, triggered by COVID-19, is an initial release of chemical signals and other inflammatory mediators secreted by lung epithelial and endothelial cells. Neutrophils and some T-lymphocytes migrate into the inflamed lung tissue and contribute to the amplification/deterioration of ARDS. A decrease in the production of lipid mediators of inflammation may impair the resolution of inflammation associated with ARDS. Ampion was reported to up regulate the production of these healing lipid mediators' prostaglandins in-vitro. In addition, multiple inflammatory signals have been reported to be attenuated by Ampion, including a decrease in vascular permeability. More than 1,000 patients with another inflammatory disease, osteoarthristis, have received Ampion without any serious drug related adverse events. A subset of these patients were given Ampion multiple times over the course of a year, and no serious drug related adverse events were observed. Ampion is formulated as a sterile liquid and is easily administered as a nebulized liquid form. If Ampion is found to be an efficacious treatment for COVID-19 induced ARDS, the company's in-house manufacturing facility may allow the product to be produced quickly and in significant quantities.The anticipated aim of a preliminary protocol for FDA review would be to evaluate patients with moderate to severe ARDS, triggered by COVID-19, for reduced ventilator time; reduction in mortality and improvements in oxygenation parameters compared to non-Ampion treated patients.

06:34 EDT Elanco: Acquisition of Bayer's animal health business seen closing mid year - Elanco's (ELAN) excitement related to the addition of Bayer's (BAYRY) animal health business is unabated by the COVID-19 situation as it confirms the value of diversifying our companion animal business into the over-the-counter market. Likewise, the expanded global scale puts Elanco in a stronger position to weather tough business environments over the long-term as the combined company focuses on innovating to meet unmet needs of animals for veterinarians, farmers and pet owners across the globe. The pending acquisition continues to advance toward a mid-year 2020 closing. Elanco has received regulatory clearance in China, Colombia, Turkey and the Ukraine, and is continuing to collaborate with other key jurisdictions. Elanco has signed agreements to divest certain products it anticipates will be necessary to complete these reviews. Further, Elanco has fully secured financing to complete the transaction through its completed equity issuance and pricing of its Term Loan B earlier in the first quarter. Given the recent decline in interest rates, Elanco entered into derivative transactions to swap a portion of its floating interest rate on the $4.275B Term Loan B to a fixed rate obligation. These derivative transactions provide greater certainty on the Term Loan B interest expense. Elanco's first significant obligation after completing the acquisition is its $500M in senior notes due August 27, 2021. Both Bayer and Elanco continue to collaborate virtually, making significant progress toward Day 1 readiness, integration planning and value capture.

06:31 EDT Gorman-Rupp to continue operating facilities in Ohio - The Gorman-Rupp will continue to conduct business at all of its locations within the State of Ohio because it is an "Essential Business" pursuant to the Director's Stay at Home Order issued by the State of Ohio in response to the COVID-19 outbreak. The Stay at Home Order is effective 11:59 p.m. on March 23 until 11:59 p.m. on April 6. The Company intends to continue operating its manufacturing facilities in the State of Ohio while complying with all applicable laws and will be following the recommendations and guidelines of both our local and State government and the Centers for Disease Control.

06:14 EDT EnLink Midstream cuts quarterly distribution by 50%, provides strategy update - EnLink Midstream announced an update regarding its financial strategy, including a reduction in its quarterly common unit distribution and additional reductions in operating and general and administrative expenses. EnLink's board has approved a reduction in its quarterly common unit distribution to 9.38c per unit, from 18.75c per unit paid for Q4, reflecting a 50% reduction. This reduction results in approximately $185M of additional cash available to EnLink for FY20, which it intends to apply towards liquidity preservation and balance sheet management. EnLink continues to identify and implement numerous expense reduction initiatives and is currently targeting $50M of incremental expense savings across its cost structure during 2020, which is in addition to the expense savings initiated during Q4. On March 17, EnLink announced a 30% reduction in 2020 total capital expenditures, net to EnLink, which will result in approximately $115M of incremental 2020 cash flow based on the midpoint of EnLink's latest guidance range. Furthermore, EnLink continues to evaluate additional reductions to capital expenditures, excluding maintenance expenditures, as a significant portion of EnLink's 2020 capital expenditures is flexible and can be managed according to producer activity. EnLink exited 2019 with a $1.75B unsecured revolving credit facility, upon which only approximately $350M was drawn, and no near-term debt maturities. EnLink's unsecured revolving credit facility is backed by 21 global financial institutions, and 17 of those institutions are lenders of EnLink's term loan, which does not mature until December 2021. In the event capital markets remain challenging, EnLink has the option of repaying the term loan by drawing on the unsecured revolving credit facility, which matures in early 2024, with no impact to leverage metrics or covenant calculations. EnLink's first maturity on its senior notes is during the first quarter of 2024. Approximately 35% of EnLink's outstanding senior notes have a remaining tenor of more than 20 years, and all outstanding senior notes are unsecured.

06:11 EDT Precision Drilling reaffirms 2020 debt reduction targeted range - Considering the new macro environment with highly volatile commodity prices, Precision reaffirms its strategic priorities for 2020: Generate strong free cash flow and utilize $100M-$150M to reduce debt in 2020. Precision reaffirms its 2020 debt reduction targeted range. As a component of this priority, in the near term, the company will focus on maximizing free cash flow by reducing capital spending by 50% and fixed costs by over 30%. As of March 24, the company has redeemed $41M of its debt in 2020 and will continue prioritizing its 2021 senior notes during the year.

06:08 EDT Humana announces change in location of Annual Meeting of Stockholders - Humana provided notice of a change in location for the company's 2020 Annual Meeting of Stockholders via the filing of additional proxy materials with the SEC. Due to the ongoing public health impact of the coronavirus disease 2019 outbreak the company will hold its 2020 Annual Meeting in a virtual meeting format only, via live webcast. As previously announced, the Annual Meeting will be held on Thursday, April 23 at 9:30 a.m., Eastern Time. The company urges stockholders to vote and submit proxies in advance of the Annual Meeting by one of the methods described in the proxy materials for the Annual Meeting.

06:06 EDT Precision Drilling announces fixed cost reductions - Precision is taking measures to enhance free cash flow by reducing fixed operating overhead and G&A costs throughout the organization, including:CEO salary reduction of 20%; Board of Director compensation reductions of 20%; Executive officer salary reductions of 10%; Staff headcount and salary reductions; Elimination of all non-essential travel, entertaining and other discretionary spending. "We expect these fixed cost reduction measures will reduce annualized fixed costs by over 30%, including up to a $30 million reduction in G&A expense."

06:02 EDT Novavax: Phase 3 clinical trial of NanoFlu achieves primary endpoints - Novavax announced positive top-line results of its pivotal Phase 3 clinical trial of NanoFlu, its recombinant quadrivalent seasonal influenza vaccine candidate with its proprietary Matrix-M adjuvant, in adults aged 65 and older. Using the FDA's criteria for accelerated approval of seasonal influenza vaccines, the trial evaluated the immunogenicity and safety of NanoFlu compared to Fluzone Quadrivalent, a U.S.-licensed quadrivalent influenza vaccine. The trial's primary objectives were to demonstrate non-inferior immunogenicity of NanoFlu compared to Fluzone Quadrivalent using the day 28 ratio of geometric mean titers and the difference in seroconversion rates, as well as the overall safety of NanoFlu. Immunogenicity was measured by hemagglutination inhibition assays using egg-derived reagents. NanoFlu achieved the primary endpoints, both GMT and SCR, for all four strains included in the vaccine. NanoFlu was well-tolerated and had a safety profile comparable to Fluzone Quadrivalent with a modest increase in local adverse events. "With these data, we now have a clear path forward to licensure with our differentiated recombinant influenza vaccine," said Stanley Erck, President and CEO of Novavax. "These strong Phase 3 results align with and validate our previous clinical trials, in which NanoFlu showed higher HAI antibody responses than the leading flu vaccine for older adults. We expect that both Fast Track designation and the accelerated approval pathway from the FDA will help Novavax bring NanoFlu to market as quickly as possible to address the serious public health threat of influenza."

05:54 EDT Qiagen releases QIAstat-Dx test kit to U.S. - Qiagen announced that it has begun shipments to the United States of its new QIAstat-Dx Respiratory SARS-CoV-2 Panel test to aid in diagnosing patients infected with the novel COVID-19 coronavirus under a new Policy of the FDA announced on March 16. Qiagen will submit this week the related Emergency Use Authorization to the FDA. The QIAstat-Dx test kit can differentiate the SARS-CoV-2 coronavirus from 20 other respiratory infections in patients who may have similar symptoms in a single testing run of about one hour. It is a multiplexed nucleic acid test that evaluates samples such as nasopharyngeal swabs obtained from individuals suspected of respiratory tract infections. This new panel includes assays targeting two genes used to detect SARS-CoV-2, the pathogen behind the disease.

05:43 EDT CNH Industrial confirms resignation of CEO - In response to a request from Borsa Italiana, the Italian Stock Exchange, CNH Industrial confirms that Hubertus Muhlhauser resigned as CEO of CNH Industrial to pursue other interests. While Mr. Muhlhauser offered to assist the company while it searched for a successor, the board determined that the company had access to appropriate experience and skills and decided therefore to accept his resignation with immediate effect.

05:36 EDT Masimo offers hospitals rainbow blood constituent monitoring licenses at no cost - Masimo announced that, in response to current worldwide blood shortages driven by the coronavirus pandemic, it is making rainbow licenses available for no additional charge to hospitals where rainbow-ready devices are already in use. The Masimo rainbow platform allows for the noninvasive and continuous monitoring of 12 parameters, including hemoglobin, oxyhemoglobin, and methemoglobin. Once rainbow is enabled, hospitals can purchase RD rainbow sensors at discounted prices during this pandemic. The program is available globally and is planned to continue until the pandemic subsides.